JP7591881B2 - Skin preparations - Google Patents
Skin preparations Download PDFInfo
- Publication number
- JP7591881B2 JP7591881B2 JP2020115937A JP2020115937A JP7591881B2 JP 7591881 B2 JP7591881 B2 JP 7591881B2 JP 2020115937 A JP2020115937 A JP 2020115937A JP 2020115937 A JP2020115937 A JP 2020115937A JP 7591881 B2 JP7591881 B2 JP 7591881B2
- Authority
- JP
- Japan
- Prior art keywords
- exercise
- extract
- oil
- acid
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 85
- 239000000284 extract Substances 0.000 claims description 108
- 230000000694 effects Effects 0.000 claims description 58
- 230000000699 topical effect Effects 0.000 claims description 55
- 230000035900 sweating Effects 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 23
- 240000003296 Petasites japonicus Species 0.000 claims description 18
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 16
- 235000000421 Lepidium meyenii Nutrition 0.000 claims description 16
- 240000000759 Lepidium meyenii Species 0.000 claims description 16
- 235000012902 lepidium meyenii Nutrition 0.000 claims description 16
- 235000003823 Petasites japonicus Nutrition 0.000 claims description 15
- 241000909582 Tambourissa Species 0.000 claims description 15
- 235000001436 butterbur Nutrition 0.000 claims description 15
- 241001026287 Chrysanthellum indicum Species 0.000 claims description 3
- -1 etc.) Chemical compound 0.000 description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- 235000014113 dietary fatty acids Nutrition 0.000 description 31
- 239000000194 fatty acid Substances 0.000 description 31
- 229930195729 fatty acid Natural products 0.000 description 31
- 239000000203 mixture Substances 0.000 description 30
- 230000001965 increasing effect Effects 0.000 description 29
- 230000035807 sensation Effects 0.000 description 28
- 208000008454 Hyperhidrosis Diseases 0.000 description 27
- 150000004665 fatty acids Chemical class 0.000 description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- 239000003921 oil Substances 0.000 description 23
- 235000019198 oils Nutrition 0.000 description 22
- 230000001737 promoting effect Effects 0.000 description 20
- 210000004243 sweat Anatomy 0.000 description 20
- 239000004615 ingredient Substances 0.000 description 19
- 229920001296 polysiloxane Polymers 0.000 description 19
- 239000003925 fat Substances 0.000 description 17
- 235000019197 fats Nutrition 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 241000196324 Embryophyta Species 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 15
- 238000009472 formulation Methods 0.000 description 15
- 239000003205 fragrance Substances 0.000 description 15
- 230000002459 sustained effect Effects 0.000 description 15
- 150000003626 triacylglycerols Chemical group 0.000 description 15
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 14
- 238000000354 decomposition reaction Methods 0.000 description 14
- 230000017531 blood circulation Effects 0.000 description 13
- 239000000419 plant extract Substances 0.000 description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 11
- 239000004359 castor oil Substances 0.000 description 11
- 235000019438 castor oil Nutrition 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 11
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 11
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 11
- 230000036760 body temperature Effects 0.000 description 10
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 10
- 229960004203 carnitine Drugs 0.000 description 10
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 235000020221 chamomile extract Nutrition 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 229920002674 hyaluronan Polymers 0.000 description 9
- 229960003160 hyaluronic acid Drugs 0.000 description 9
- 230000001976 improved effect Effects 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 241000208838 Asteraceae Species 0.000 description 8
- 240000003538 Chamaemelum nobile Species 0.000 description 8
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 210000003470 mitochondria Anatomy 0.000 description 8
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 7
- 229940119217 chamomile extract Drugs 0.000 description 7
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 6
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 6
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 6
- 229960002216 methylparaben Drugs 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- 244000228451 Stevia rebaudiana Species 0.000 description 5
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 5
- 229960001948 caffeine Drugs 0.000 description 5
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 5
- 238000002485 combustion reaction Methods 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 210000001700 mitochondrial membrane Anatomy 0.000 description 5
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000019157 thiamine Nutrition 0.000 description 5
- 239000011721 thiamine Substances 0.000 description 5
- 229960003495 thiamine Drugs 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- 241000219193 Brassicaceae Species 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 4
- 102000001406 Perilipin Human genes 0.000 description 4
- 108060006002 Perilipin Proteins 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 102000000019 Sterol Esterase Human genes 0.000 description 4
- 108010055297 Sterol Esterase Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 210000001789 adipocyte Anatomy 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000010642 eucalyptus oil Substances 0.000 description 4
- 229940044949 eucalyptus oil Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 4
- 235000019161 pantothenic acid Nutrition 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 4
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241001105098 Angelica keiskei Species 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000195619 Euglena gracilis Species 0.000 description 3
- 206010016334 Feeling hot Diseases 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 239000000783 alginic acid Substances 0.000 description 3
- 229960001126 alginic acid Drugs 0.000 description 3
- 150000004781 alginic acids Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 210000001217 buttock Anatomy 0.000 description 3
- 230000002612 cardiopulmonary effect Effects 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 150000003943 catecholamines Chemical class 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 3
- 239000005516 coenzyme A Substances 0.000 description 3
- 229940093530 coenzyme a Drugs 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000010651 grapefruit oil Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229940102545 peg-20 sorbitan isostearate Drugs 0.000 description 3
- 239000002831 pharmacologic agent Substances 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- IWLROWZYZPNOFC-UHFFFAOYSA-O thiamine triphosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N IWLROWZYZPNOFC-UHFFFAOYSA-O 0.000 description 3
- 239000003860 topical agent Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 102100035905 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 Human genes 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- VLDFMKOUUQYFGF-UHFFFAOYSA-N 4-(butoxymethyl)-2-methoxyphenol Chemical compound CCCCOCC1=CC=C(O)C(OC)=C1 VLDFMKOUUQYFGF-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- 244000141218 Alpinia officinarum Species 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- 241000218157 Aquilegia vulgaris Species 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 2
- 241000282994 Cervidae Species 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 241000336316 Cistanche tubulosa Species 0.000 description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 description 2
- 240000000171 Crataegus monogyna Species 0.000 description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 241000195620 Euglena Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 241000981786 Globularia cordifolia Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 101000929840 Homo sapiens 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 Proteins 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000721662 Juniperus Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 235000019537 butterbur extract Nutrition 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 235000011087 fumaric acid Nutrition 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 235000020708 ginger extract Nutrition 0.000 description 2
- 229940002508 ginger extract Drugs 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 244000237330 gutta percha tree Species 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 238000000968 medical method and process Methods 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 229960005010 orotic acid Drugs 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 150000002948 pantothenic acids Chemical class 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 239000001622 pimenta officinalis fruit oil Substances 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 239000001738 pogostemon cablin oil Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 239000010671 sandalwood oil Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 208000013460 sweaty Diseases 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- 235000020955 thiamine monophosphate Nutrition 0.000 description 2
- 239000011621 thiamine monophosphate Substances 0.000 description 2
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 2
- 239000011678 thiamine pyrophosphate Substances 0.000 description 2
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 2
- GUGWNSHJDUEHNJ-UHFFFAOYSA-N thiamine(1+) monophosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N GUGWNSHJDUEHNJ-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 229940078465 vanillyl butyl ether Drugs 0.000 description 2
- 239000010679 vetiver oil Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- JYVXNLLUYHCIIH-UHFFFAOYSA-N (+/-)-mevalonolactone Natural products CC1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-UHFFFAOYSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- OAJLVMGLJZXSGX-CXGXMSGESA-L (2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4z,9z,14z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8 Chemical compound [Co+3].O[C@@H]1[C@H](O)[C@@H]([CH2-])O[C@H]1N1C2=NC=NC(N)=C2N=C1.O([C@H]1[C@H]([C@H](O[C@@H]1CO)N1C2=CC(C)=C(C)C=C2N=C1)O)P([O-])(=O)OC(C)CNC(=O)CCC1(C)C(CC(N)=O)C2[N-]\C1=C(C)/C(C(C\1(C)C)CCC(N)=O)=N/C/1=C\C(C(C/1(CC(N)=O)C)CCC(N)=O)=N\C\1=C(C)/C1=NC2(C)C(C)(CC(N)=O)C1CCC(N)=O OAJLVMGLJZXSGX-CXGXMSGESA-L 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- OMSJCIOTCFHSIT-MXYBEHONSA-N (3s,3ar,6s,6as)-3,6,6a-trihydroxy-6-(1h-indol-3-ylmethyl)-3,3a-dihydro-2h-furo[3,2-b]furan-5-one Chemical compound C1=CC=C2C(C[C@@]3(O)C(=O)O[C@H]4[C@]3(O)OC[C@@H]4O)=CNC2=C1 OMSJCIOTCFHSIT-MXYBEHONSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- VUICSPKQAQGLBU-UHFFFAOYSA-N 1-(4-methylphenyl)ethyl pyridine-3-carboxylate Chemical compound C=1C=C(C)C=CC=1C(C)OC(=O)C1=CC=CN=C1 VUICSPKQAQGLBU-UHFFFAOYSA-N 0.000 description 1
- YAYNEUUHHLGGAH-UHFFFAOYSA-N 1-chlorododecane Chemical compound CCCCCCCCCCCCCl YAYNEUUHHLGGAH-UHFFFAOYSA-N 0.000 description 1
- CLWAXFZCVYJLLM-UHFFFAOYSA-N 1-chlorohexadecane Chemical compound CCCCCCCCCCCCCCCCCl CLWAXFZCVYJLLM-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- DJCYDDALXPHSHR-UHFFFAOYSA-N 2-(2-propoxyethoxy)ethanol Chemical compound CCCOCCOCCO DJCYDDALXPHSHR-UHFFFAOYSA-N 0.000 description 1
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 1
- UHDPBLMLEMNPKP-UHFFFAOYSA-M 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol thiocyanate Chemical compound [S-]C#N.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UHDPBLMLEMNPKP-UHFFFAOYSA-M 0.000 description 1
- FQNKTJPBXAZUGC-UHFFFAOYSA-N 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoic acid Chemical compound OC1=CC(N(CC)CC)=CC=C1C(=O)C1=CC=CC=C1C(O)=O FQNKTJPBXAZUGC-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- LDMRLRNXHLPZJN-UHFFFAOYSA-N 3-propoxypropan-1-ol Chemical compound CCCOCCCO LDMRLRNXHLPZJN-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- TZZAKSLHHIJRLL-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1O TZZAKSLHHIJRLL-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- JKAJKJLFNPXQDU-UHFFFAOYSA-N 5-ethyl-1-hexyl-4,5-dihydrotriazole Chemical compound CCCCCCN1N=NCC1CC JKAJKJLFNPXQDU-UHFFFAOYSA-N 0.000 description 1
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000011446 Amygdalus persica Nutrition 0.000 description 1
- 241000944022 Amyris Species 0.000 description 1
- 241000544270 Angelica acutiloba Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000271309 Aquilaria crassna Species 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- OMSJCIOTCFHSIT-UHFFFAOYSA-N Ascorbigen A Natural products C1=CC=C2C(CC3(O)C(=O)OC4C3(O)OCC4O)=CNC2=C1 OMSJCIOTCFHSIT-UHFFFAOYSA-N 0.000 description 1
- 239000004261 Ascorbyl stearate Substances 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- UUGLJVMIFJNVFH-UHFFFAOYSA-N Benzoesaeure-n-hexylester Natural products CCCCCCOC(=O)C1=CC=CC=C1 UUGLJVMIFJNVFH-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- MOZDKDIOPSPTBH-UHFFFAOYSA-N Benzyl parahydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OCC1=CC=CC=C1 MOZDKDIOPSPTBH-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 208000031636 Body Temperature Changes Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 241000202722 Bupleurum falcatum Species 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 241000020085 Chrysanthellum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 240000008632 Cota tinctoria Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- SBJKKFFYIZUCET-UHFFFAOYSA-N Dehydroascorbic acid Natural products OCC(O)C1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- AZJUFRDUYTYIHV-NKFKGCMQSA-N Dibenzoyl Thiamine Chemical compound C=1C=CC=CC=1C(=O)OCC\C(SC(=O)C=1C=CC=CC=1)=C(/C)N(C=O)CC1=CN=C(C)N=C1N AZJUFRDUYTYIHV-NKFKGCMQSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- HDOMLWFFJSLFBI-UHFFFAOYSA-N Eriocitrin Natural products CC1OC(OCC2OC(Oc3cc(O)c4C(=O)CC(Oc4c3)c5ccc(OC6OC(COC7OC(C)C(O)C(O)C7O)C(O)C(O)C6O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O HDOMLWFFJSLFBI-UHFFFAOYSA-N 0.000 description 1
- OMQADRGFMLGFJF-MNPJBKLOSA-N Eriodictioside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=C(O)C(O)=CC=2)O1 OMQADRGFMLGFJF-MNPJBKLOSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 241000557129 Glaucium Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- 229920001499 Heparinoid Polymers 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000384508 Hoplostethus atlanticus Species 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 1
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 244000255365 Kaskarillabaum Species 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000039951 Lithocarpus glaber Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000213879 Lyssa Species 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000004429 Matricaria chamomilla var recutita Nutrition 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 241001529735 Melissa Species 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 102000005398 Monoacylglycerol Lipase Human genes 0.000 description 1
- 108020002334 Monoacylglycerol lipase Proteins 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- PSFABYLDRXJYID-VKHMYHEASA-N N-Methylserine Chemical compound CN[C@@H](CO)C(O)=O PSFABYLDRXJYID-VKHMYHEASA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- PSFABYLDRXJYID-UHFFFAOYSA-N N-methyl-DL-serine Natural products CNC(CO)C(O)=O PSFABYLDRXJYID-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- IDEOITKGHXRKLG-UHFFFAOYSA-N Oxo-octadecadienoic acid Chemical compound CCCCCCCCCCCCC(=O)C=CC=CC(O)=O IDEOITKGHXRKLG-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-WCXIOVBPSA-N Pangamic acid Chemical compound CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RVSTWRHIGKXTLG-WCXIOVBPSA-N 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000206607 Porphyra umbilicalis Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000206608 Pyropia tenera Species 0.000 description 1
- 241000206613 Pyropia yezoensis Species 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- JYVXNLLUYHCIIH-ZCFIWIBFSA-N R-mevalonolactone, (-)- Chemical compound C[C@@]1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-ZCFIWIBFSA-N 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000003500 Ruscus aculeatus Nutrition 0.000 description 1
- 240000000353 Ruscus aculeatus Species 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 241000220156 Saxifraga Species 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241001530209 Swertia Species 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- QEKBRBCVWVLFHH-QAKUKHITSA-L Tocopherol calcium succinate Chemical compound [Ca+2].[O-]C(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C.[O-]C(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C QEKBRBCVWVLFHH-QAKUKHITSA-L 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000196252 Ulva Species 0.000 description 1
- 241001261506 Undaria pinnatifida Species 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- NARKTLKJPPMFJF-LEJQEAHTSA-N [(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl n-[(2s)-2,6-diaminohexanoyl]sulfamate Chemical compound O[C@@H]1[C@H](O)[C@@H](COS(=O)(=O)NC(=O)[C@@H](N)CCCCN)O[C@H]1N1C2=NC=NC(N)=C2N=C1 NARKTLKJPPMFJF-LEJQEAHTSA-N 0.000 description 1
- TXGSMRRWACWHFZ-MVIDNBQJSA-N [(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-tris(pyridine-3-carbonyloxy)pentyl] pyridine-3-carboxylate Chemical compound O([C@@H](CN1C=2C(C(NC(=O)N=2)=O)=NC=2C=C(C(=CC=21)C)C)[C@H](OC(=O)C=1C=NC=CC=1)[C@@H](COC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 TXGSMRRWACWHFZ-MVIDNBQJSA-N 0.000 description 1
- DDEDPQYNISJXLF-XTMYEIJHSA-N [(z)-4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-benzoylsulfanylpent-3-enyl] benzoate;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(=O)OCC\C(SC(=O)C=1C=CC=CC=1)=C(/C)N(C=O)CC1=CN=C(C)N=C1N DDEDPQYNISJXLF-XTMYEIJHSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- VVNANPHBTSDUIH-UHFFFAOYSA-N [5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl acetate Chemical compound CC(=O)OCC1=CN=C(C)C(O)=C1CO VVNANPHBTSDUIH-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000001269 achillea millefolium l. oil Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 235000019276 ascorbyl stearate Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- IZJRISIINLJVBU-UHFFFAOYSA-N beta-Butoxyethyl nicotinate Chemical compound CCCCOCCOC(=O)C1=CC=CN=C1 IZJRISIINLJVBU-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000010629 calamus oil Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000010624 camphor oil Substances 0.000 description 1
- 229960000411 camphor oil Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 239000001507 cistus ladaniferus l. oil Substances 0.000 description 1
- 239000010632 citronella oil Substances 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000010633 clary sage oil Substances 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000001555 commiphora myrrha gum extract Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 235000020960 dehydroascorbic acid Nutrition 0.000 description 1
- 239000011615 dehydroascorbic acid Substances 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 1
- 229940013640 flavin mononucleotide Drugs 0.000 description 1
- 239000011768 flavin mononucleotide Substances 0.000 description 1
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 1
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 229940118127 fucus vesiculosus extract Drugs 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 239000010646 galangal oil Substances 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229940052308 general anesthetics halogenated hydrocarbons Drugs 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940108690 glucosyl hesperidin Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 239000002554 heparinoid Substances 0.000 description 1
- 229940025770 heparinoids Drugs 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 239000000175 humulus lupulus l. cone oil Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000004867 hydroxocobalamin Nutrition 0.000 description 1
- 239000011704 hydroxocobalamin Substances 0.000 description 1
- 229960001103 hydroxocobalamin Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 239000001735 hyssopus officinalis l. herb oil Substances 0.000 description 1
- PPVUCLAYECHOQZ-UHFFFAOYSA-N imidazolidine-4,5-dione Chemical compound O=C1NCNC1=O PPVUCLAYECHOQZ-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 239000008633 juniper tar Substances 0.000 description 1
- 239000001851 juniperus communis l. berry oil Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- GUMSHIGGVOJLBP-SLRPQMTOSA-N methyl hesperidin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 GUMSHIGGVOJLBP-SLRPQMTOSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960001238 methylnicotinate Drugs 0.000 description 1
- 229940057061 mevalonolactone Drugs 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 239000010659 mugwort oil Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 229940055705 pangamic acid Drugs 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 239000001631 piper nigrum l. fruit oil black Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- FCHXJFJNDJXENQ-UHFFFAOYSA-N pyridoxal hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(C=O)=C1O FCHXJFJNDJXENQ-UHFFFAOYSA-N 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- PFIPZKASKUWLHH-UHFFFAOYSA-N pyridoxamine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CN)=C1O PFIPZKASKUWLHH-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229950001574 riboflavin phosphate Drugs 0.000 description 1
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 150000003410 sphingosines Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- HZSAJDVWZRBGIF-UHFFFAOYSA-M thiamine(1+) monophosphate(2-) Chemical compound CC1=C(CCOP([O-])([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N HZSAJDVWZRBGIF-UHFFFAOYSA-M 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 239000010681 turmeric oil Substances 0.000 description 1
- 150000003669 ubiquinones Chemical class 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
特許法第30条第2項適用 2019年6月20日に2019年度FIAリーダーズシンポジウムにて「propo(ウォーミングセラム)」の販売促進用資料を配付Article 30, paragraph 2 of the Patent Act applied. Promotional materials for "propo (Warming Serum)" were distributed at the 2019 FIA Leaders Symposium on June 20, 2019.
本発明は、運動による効果を持続又は向上させることができる皮膚外用剤に関する。 The present invention relates to an external skin preparation that can maintain or improve the effects of exercise.
便利な世の中になるにつれ、日常生活で身体を動かすことが少なくなり、多くの人が運動不足を感じている。このため、日常的に運動又はスポーツをする人が増えている。その目的は様々であり、筋力や持久力の維持又は向上のため、心肺機能の向上のため、生活習慣病の予防など健康を維持するため、加齢に伴う身体機能低下の予防のため、腰やひざの痛みの軽減のため、血行促進のため、痩せるためといった身体的効果を目的とする場合の他、気分転換やストレス解消のため、認知症予防のため、不定愁訴の改善のためといった精神的効果を目的とする場合もある。また、筋力、持久力、心肺機能などの向上を目的とする、強度が非常に大きい運動から、健康維持やストレス解消を目的とする、強度がそれほど大きくない運動まで様々である。 As the world becomes more convenient, people move their bodies less in their daily lives, and many people feel that they are not getting enough exercise. For this reason, more and more people are exercising or playing sports on a daily basis. There are various reasons for exercising, including physical effects such as maintaining or improving muscle strength and endurance, improving cardiopulmonary function, maintaining health by preventing lifestyle-related diseases, preventing decline in physical function due to aging, relieving pain in the lower back or knees, promoting blood circulation, and losing weight, as well as mental effects such as changing one's mood or relieving stress, preventing dementia, and improving vague symptoms. Exercising can range from very high-intensity exercise aimed at improving muscle strength, endurance, cardiopulmonary function, etc., to less intense exercise aimed at maintaining health and relieving stress.
筋力、持久力、心肺機能などの向上を目的とする、強度が非常に大きい運動の場合、運動後は、運動量を徐々に減らしたり、ストレッチをしたりする、アクティブレストや、負荷をかけることで傷ついた筋組織の修復を促すため、氷や外用剤で筋肉を冷やしつつ(アイシング)、マッサージするなどのクールダウンを行うことが良いとされている(非特許文献1、2)。そのため、クールダウンのための器具や皮膚外用剤は、多く市販されている。 When exercising at a very high intensity to improve muscle strength, endurance, cardiopulmonary function, etc., it is recommended that after exercise, active rest be performed, such as gradually reducing the amount of exercise, stretching, or cooling down by cooling the muscles with ice or topical agents (icing) and massaging them to promote the repair of muscle tissue damaged by the load (Non-Patent Documents 1 and 2). For this reason, many cooling-down devices and topical skin agents are commercially available.
一方、これまで強度がそれほど大きくない運動の場合は、運動中及び後のケアについて、何ら提唱されてはいなかった。しかしながら、近年の生活環境や労働環境等の変化により、健康維持やストレス解消などの目的で軽い運動をする人が増えている。本発明者は、これら軽い運動をする人は、その運動頻度も低いため、運動した後の気持ちの良い感覚が持続することが好む傾向があることを見出した。即ち、軽い運動でしっかり運動したという実感を得たい、運動効果の効率向上または運動の時短を図りたいという新たなニーズを見出した。具体的には、ポカポカする、汗をかくなどの感覚が続くことで、しっかり運動したことを長く感じていたい、ウォームダウンをしたい等の要望である。 On the other hand, until now, no advice has been given on care during or after exercise for exercise that is not very intense. However, due to recent changes in living and working environments, an increasing number of people are engaging in light exercise for the purposes of maintaining health and relieving stress. The inventors have found that, because these light exercisers do not exercise frequently, they tend to prefer a long-lasting pleasant feeling after exercise. In other words, they have found new needs, such as the desire to feel like they have exercised well with light exercise, and the desire to improve the efficiency of the exercise effect or shorten the time required for exercise. Specifically, these are requests for a long-lasting feeling of warmth and sweating, so that they can feel like they have exercised well for a long time, and for warming down.
ところが、筋肉のクールダウンのための皮膚外用剤は多く市販されているが、運動後も温まった身体を冷やさないようにしたり、運動により得られる温感、爽快感などの気持ちの良い感覚を維持したりするための皮膚外用剤は知られていない。 However, although there are many topical skin preparations on the market that can cool down muscles, no topical skin preparations are known that can keep the body warm after exercise from cooling down or that can maintain the pleasant sensations, such as the warmth and refreshing feeling, that come with exercise.
そこで、本発明は、運動により得られる効果を持続又は増大させることができる皮膚外用剤を提供することを課題とする。 Therefore, the objective of the present invention is to provide an external skin preparation that can sustain or enhance the effects obtained through exercise.
本発明者は、上記課題を解決するために研究を重ね、運動に際して、脂肪の燃焼を促進する成分と発汗を促進する成分を含む組成物を皮膚に適用することで、体温上昇、発汗などの運動による効果が効果的に持続することを見出した。 The inventors conducted extensive research to solve the above problems and discovered that by applying a composition containing a component that promotes fat burning and a component that promotes sweating to the skin during exercise, the effects of exercise, such as increased body temperature and sweating, can be effectively sustained.
本発明は、上記知見に基づき完成されたものであり、下記の皮膚外用剤を提供する。
〔1〕 (A)脂肪の燃焼を促進する成分、及び(B)発汗を促進する成分を含む皮膚外用剤。
〔2〕 (A)成分が(A1)トリグリセリドの分解を促進する作用を有する成分、(A2)トリグリセリドの分解により生成した脂肪酸の取り込み促進作用を有する成分、及び(A3)ミトコンドリア内での脂肪酸の燃焼を促進する作用を有する成分からなる群より選ばれる少なくとも1種である、〔1〕に記載の皮膚外用剤。
〔3〕 (A1)成分がキク科植物抽出物であり、(A2)成分がL-カルニチンであり、(A3)成分がアブラナ科植物抽出物である、〔2〕に記載の皮膚外用剤。
〔4〕 (B)成分として、タンブリッサトリコフィラ抽出物、及び/又はキク科植物抽出物を含む、〔1〕~〔3〕の何れかに記載の皮膚外用剤。
〔5〕 (A)成分の総含有量が、植物抽出物については乾燥重量に換算して、皮膚外用剤の全量に対して、0.0002~10重量%である、〔1〕~〔4〕の何れかに記載の皮膚外用剤。
〔6〕 (B)成分の総含有量が、植物抽出物については乾燥重量に換算して、皮膚外用剤の全量に対して、0.0001~10重量%である、〔1〕~〔5〕の何れかに記載の皮膚外用剤。
〔7〕 さらに、香料を含む、〔1〕~〔6〕の何れかに記載の皮膚外用剤。
〔8〕 運動効果の持続又は向上のために用いられる、〔1〕~〔7〕の何れかに記載の皮膚外用剤。
〔9〕 運動効果の持続又は向上が、皮膚温度、発汗、血流、及び/又は爽快感の維持又は向上である、〔8〕に記載の皮膚外用剤。
〔10〕 運動中、又は運動後に皮膚に適用される、〔1〕~〔9〕の何れかに記載の皮膚外用剤。
〔11〕 運動に際して、(A)脂肪の燃焼を促進する成分、及び(B)発汗を促進する成分を含む皮膚外用剤を皮膚に適用する工程を含む運動効果の持続又は向上方法。
The present invention has been completed based on the above findings, and provides the following external skin preparation.
[1] A skin topical preparation comprising (A) a component that promotes fat burning, and (B) a component that promotes sweating.
[2] The topical skin preparation according to [1], wherein the component (A) is at least one selected from the group consisting of (A1) a component having the effect of promoting the decomposition of triglycerides, (A2) a component having the effect of promoting the uptake of fatty acids produced by the decomposition of triglycerides, and (A3) a component having the effect of promoting the combustion of fatty acids in mitochondria.
[3] The external skin preparation according to [2], wherein the component (A1) is an extract of a plant of the Asteraceae family, the component (A2) is L-carnitine, and the component (A3) is an extract of a plant of the Brassicaceae family.
[4] The skin external preparation according to any one of [1] to [3], comprising Tambourissa trichophylla extract and/or Asteraceae plant extract as component (B).
[5] The topical skin preparation according to any one of [1] to [4], wherein the total content of the component (A) is, in terms of the plant extract, 0.0002 to 10% by weight, based on the total amount of the topical skin preparation, calculated on a dry weight basis.
[6] The topical skin preparation according to any one of [1] to [5], wherein the total content of the component (B) is, in terms of the plant extract, 0.0001 to 10% by weight based on the total amount of the topical skin preparation, calculated on a dry weight basis.
[7] The external skin preparation according to any one of [1] to [6], further comprising a fragrance.
[8] The external skin preparation according to any one of [1] to [7], which is used for sustaining or improving the effect of exercise.
[9] The external skin preparation according to [8], wherein the sustained or improved exercise effect is the maintenance or improvement of skin temperature, sweating, blood flow, and/or a sense of refreshment.
[10] The external skin preparation according to any one of [1] to [9], which is applied to the skin during or after exercise.
[11] A method for maintaining or improving the effects of exercise, comprising the step of applying to the skin during exercise an external skin preparation comprising (A) a component that promotes fat burning and (B) a component that promotes sweating.
本発明の皮膚外用剤を、運動の際に、皮膚に適用すると、運動により得られる効果が持続又は向上する。このため、軽い運動でも、しっかり運動したという実感(実効感)が得られ、満足感が得られる。具体的には、運動により上昇した体温(特に、皮膚又は体表面温度)、運動による発汗増大、運動による血流増大、運動による爽快状態などが持続又は増大する。
通常、運動により体温(特に、皮膚又は体表面温度)は上昇するものの、運動を止めると体温上昇が緩やかになったり、汗の蒸散により却って低下したりするが、本発明の皮膚外用剤を使用すると、発汗が持続するにも拘らず、運動により上昇した体温(特に、皮膚又は体表面温度)が維持され、さらに体温上昇する場合もある。また、本発明の皮膚外用剤を使用することにより、運動後の発汗が持続し、また発汗量が増大する。
また、運動後の気持ちの良い感覚ないしは体感、例えば、ポカポカする温感、発汗感、血流増大感、爽快感も持続又は増大する。
When the skin preparation of the present invention is applied to the skin during exercise, the effect of exercise is sustained or improved. Therefore, even light exercise can give a sense of having exercised well (sense of effectiveness) and a sense of satisfaction. Specifically, the body temperature (particularly skin or body surface temperature) increased by exercise, the increase in sweating due to exercise, the increase in blood flow due to exercise, the refreshing state due to exercise, etc. are sustained or increased.
Although body temperature (particularly, skin or body surface temperature) usually rises due to exercise, when exercise is stopped, the rise in body temperature slows down or even falls due to evaporation of sweat, but when the skin preparation of the present invention is used, the body temperature (particularly, skin or body surface temperature) that has risen due to exercise is maintained, even though sweating continues, and in some cases, body temperature may even rise further. In addition, by using the skin preparation of the present invention, sweating after exercise is sustained and the amount of sweating increases.
In addition, the pleasant sensations or bodily sensations after exercise, such as a warm feeling, sweating, increased blood flow, and a feeling of refreshment, are also sustained or enhanced.
また、本発明の皮膚外用剤は、運動前に使用しても効果が得られるが、運動中又は運動後に使用することで、一層効果的に、運動効果、運動実感、運動体感が持続又は向上する。 Although the skin topical preparation of the present invention is effective when used before exercise, using it during or after exercise more effectively maintains or improves the exercise effect, exercise sensation, and exercise bodily sensation.
本発明の皮膚外用剤は、(A)脂肪の燃焼を促進する成分、及び(B)発汗を促進する成分を含む製剤である。 The topical skin preparation of the present invention is a preparation that contains (A) a component that promotes fat burning and (B) a component that promotes sweating.
(A)脂肪の燃焼を促進する成分
脂肪の燃焼を促進する成分としては、(A1)トリグリセリドの分解を促進する作用を有する成分、(A2)トリグリセリドの分解により生成した脂肪酸の取り込み促進作用を有する成分、及び(A3)ミトコンドリア内での脂肪酸の燃焼を促進する作用を有する成分が挙げられる。
本発明の皮膚外用剤は、脂肪の燃焼を促進する成分を1種、又は2種以上含むことができる。また、(A1)成分、(A2)成分、及び(A3)成分の何れか一つ、又は二つ以上を含むことができる。特に、(A1)成分、(A2)成分、及び(A3)成分を含むことが好ましい。
(A) Components that promote fat burning Examples of components that promote fat burning include (A1) components having the effect of promoting the decomposition of triglycerides, (A2) components having the effect of promoting the uptake of fatty acids produced by the decomposition of triglycerides, and (A3) components having the effect of promoting the combustion of fatty acids in mitochondria.
The skin topical preparation of the present invention may contain one or more components that promote fat burning. It may also contain one or more of the components (A1), (A2), and (A3). It is particularly preferred that the skin topical preparation contains the components (A1), (A2), and (A3).
(A1)トリグリセリドの分解を促進する作用を有する成分
脂肪細胞に脂肪滴として蓄積されている脂肪は、中性脂肪、即ち、トリグリセリドである。ヒトを含む動物の中性脂肪は、様々な脂肪酸組成のトリグセリドの混合物である。
脂肪細胞において、アドレナリン、ノルアドレナリンなどのカテコールアミン系ホルモンが細胞表面の受容体に結合すると、ホルモン感受性リパーゼとペリリピンがリン酸化により活性化される。リパーゼは、トリグリセリドをグリセロールと脂肪酸に分解する酵素である。また、ペリリピンは、脂肪滴表面に結合しているタンパク質であり、平常時にはホルモン感受性リパーゼが脂肪滴に作用するのを防ぐが、カテコールアミン系ホルモン刺激によりリン酸化されると、ホルモン感受性リパーゼの作用を促進する。また、脂肪滴表面には、CGI-58と称されるタンパク質がペリリピンと相互作用して存在しているが、カテコールアミン系ホルモン刺激によりペリリピンがリン酸化されると、CGI-58が脂肪滴から遊離し、脂肪細胞特異的トリグリセリドリパーゼを活性化する。脂肪細胞特異的トリグリセリドリパーゼはホルモン感受性リパーゼよりトリグリセリドに対して特に強く作用する。さらに、トリグリセリドが完全に3つの脂肪酸とグリセロールにまで分解されるには、モノアシルグリセロールリパーゼが段階的に作用することが必要である。
(A1) Components that have the effect of promoting the decomposition of triglycerides The fat stored as lipid droplets in fat cells is neutral fat, i.e., triglycerides. The neutral fats of animals, including humans, are a mixture of triglycerides with various fatty acid compositions.
In fat cells, when catecholamine hormones such as adrenaline and noradrenaline bind to receptors on the cell surface, hormone-sensitive lipase and perilipin are activated by phosphorylation. Lipase is an enzyme that breaks down triglycerides into glycerol and fatty acids. Perilipin is a protein that is bound to the surface of fat droplets, and under normal circumstances prevents hormone-sensitive lipase from acting on fat droplets, but when it is phosphorylated by catecholamine hormone stimulation, it promotes the action of hormone-sensitive lipase. A protein called CGI-58 is present on the surface of fat droplets, interacting with perilipin, and when perilipin is phosphorylated by catecholamine hormone stimulation, CGI-58 is released from the fat droplets and activates fat cell-specific triglyceride lipase. Fat cell-specific triglyceride lipase acts particularly strongly on triglycerides compared to hormone-sensitive lipase. Furthermore, the complete decomposition of triglycerides into three fatty acids and glycerol requires the stepwise action of monoacylglycerol lipase.
トリグリセリドの分解を促進する作用を有する成分は、トリグリセリドが3つの脂肪酸とグリセロールにまで分解されるまでの何れの段階を促進するものであってもよい。
このような成分として、キク科植物(中でも、クリサンテルムインジクム(ゴールデンカモミール)のようなクリサンテルム属植物、ステビアのようなステビア属植物)の抽出物、ニーム葉抽出物、レモングラス抽出物、アシタバ抽出物、褐藻抽出物(コンブ抽出物、ヒジキ抽出物、ヒバマタ抽出物、ワカメ抽出物など)、緑藻抽出物(アオサ抽出物、アオノリ抽出物など)、紅藻抽出物(テングサ抽出物、アサクサノリ抽出物、スサビノリ抽出物など)、ナツメ(大棗)果実抽出物、トチュウ(杜仲)抽出物、クロレラ抽出物、ユーグレナグラシリス(ユーグレナ、ミドリムシとも称される)抽出物、ツノゲシ葉抽出物、グロブラリアコルジホリアカルス培養抽出物、ハナショウガ抽出物、ミシマサイコ根抽出物、コエンチームA、カフェインなどが挙げられる。
また、上記作用を有する成分の混合物としては、ユーグレナグラシリスエキス、カフェイン、及びツノゲシ葉抽出物の混合物(フィトソニック(商品名);セダーマ社)、グロブラリアコルジホリアカルス培養抽出物、カフェイン、及びハナショウガ抽出物の混合物(インテスリム(商品名);セダーマ社)、ミシマサイコ根抽出物、カフェイン、及びコエンチームAの混合物(リポケア(商品名);セダーマ社)などが挙げられる。
中でも、トリグリセリドの分解促進作用が強い点で、キク科植物(中でも、クリサンテルムインジクム、ステビア)の抽出物、ユーグレナグラシリスエキスとカフェインとツノゲシ葉抽出物の混合物(例えば、フィトソニック(セダーマ社))が好ましく、キク科植物(中でも、クリサンテルムインジクム)の抽出物がより好ましい。クリサンテルムインジクム抽出物を含有する製品として、ラナクリス(ルーカスマイヤー社)が挙げられる。
トリグリセリドの分解を促進する作用を有する成分は、1種を単独で、又は2種以上を組み合わせて使用できる。
The component having the effect of promoting the decomposition of triglycerides may promote any stage up to the decomposition of triglycerides into three fatty acids and glycerol.
Examples of such ingredients include extracts of Asteraceae plants (particularly, Chrysantherm plants such as Chrysantherm indicum (golden chamomile) and Stevia plants such as Stevia), neem leaf extract, lemongrass extract, Angelica keiskei extract, brown algae extracts (kelp extract, hijiki extract, fucus vesiculosus extract, wakame extract, etc.), green algae extracts (ulva extract, green laver extract, etc.), red algae extracts (agarwood extract, Asakusa-nori extract, Susabinori extract, etc.), jujube (Zatsume) fruit extract, Eucommia ulmoides (Eucommia ulmoides) extract, Chlorella extract, Euglena gracilis (also called Euglena or Euglena) extract, Horn poppy leaf extract, Globularia cordifolia callus culture extract, Zingiber officinale extract, Bupleurum falcatum root extract, coenzyme A, caffeine, and the like.
Examples of mixtures of ingredients having the above-mentioned effects include a mixture of Euglena gracilis extract, caffeine, and Horn Poppy leaf extract (Phytosonic (trade name); Sedama), a mixture of Globularia cordifolia callus culture extract, caffeine, and Chinese ginger extract (Inteslim (trade name); Sedama), and a mixture of Bupleurum saiko root extract, caffeine, and coenzyme A (Lipocare (trade name); Sedama).
Among them, in terms of their strong effect of promoting the decomposition of triglycerides, extracts of plants of the Asteraceae family (especially Chrysantherm indicum and Stevia) and a mixture of Euglena gracilis extract, caffeine and Corn Poppy leaf extract (e.g., Phytosonic (Sederma)) are preferred, and extracts of plants of the Asteraceae family (especially Chrysantherm indicum) are more preferred. An example of a product containing Chrysantherm indicum extract is Lanacris (Lucas Meyer).
The component having the effect of promoting the decomposition of triglycerides may be used alone or in combination of two or more.
本発明の皮膚外用剤が(A1)成分(特に、キク科植物、中でもクリサンテルム属植物及び/又はステビサ属植物、中でもクリサンテルムインジクム及び/又はステビアの抽出物)を含む場合のその含有量は、皮膚外用剤の全量に対して、0.000005重量%以上が好ましく、0.00001重量%以上がより好ましく、0.00005重量%以上がさらにより好ましい。また、1重量%以下が好ましく、0.5重量%以下がより好ましく、0.1重量%以下がさらにより好ましい。この含有量は、植物抽出物については、乾燥重量に換算した重量から算出した値である。この範囲であれば、(B)成分と共に作用して、十分に運動効果を持続又は向上させることができる。 When the skin topical preparation of the present invention contains the (A1) component (particularly an extract of a plant of the Asteraceae family, particularly a plant of the genus Chrysanthellum and/or a plant of the genus Stevisa, particularly Chrysanthellum indicum and/or Stevia), the content of the component is preferably 0.000005% by weight or more, more preferably 0.00001% by weight or more, and even more preferably 0.00005% by weight or more, based on the total amount of the skin topical preparation. Also, the content is preferably 1% by weight or less, more preferably 0.5% by weight or less, and even more preferably 0.1% by weight or less. For plant extracts, this content is a value calculated from the weight converted to dry weight. If it is within this range, it can act together with the (B) component to sufficiently maintain or improve the exercise effect.
(A2)脂肪酸の取り込み促進作用を有する成分
トリグリセリドの分解により生じた脂肪酸は、アルブミンと結合して血中を運ばれ、身体の各組織の細胞内に取り込まれる。細胞内に取り込まれた脂肪酸は、ミトコンドリア内で酸化及び分解されてエネルギーが取り出される。脂肪酸の中でも中鎖脂肪酸は他成分を介さずミトコンドリア膜を透過することができるが、長鎖脂肪酸は単独ではミトコンドリア膜を透過できない。
脂肪酸の取り込み促進作用を有する成分としては、脂肪酸の細胞内への取り込みを促進する作用を有する成分と、細胞内に取り込まれた脂肪酸をミコンドリア内に運搬させる作用又はミトコンドリア膜を透過させる作用を有する成分が挙げられる。
(A2) Components with Fatty Acid Uptake Promoting Effects Fatty acids produced by the decomposition of triglycerides are bound to albumin and transported in the blood, and are taken up into the cells of various tissues of the body. The fatty acids taken up into the cells are oxidized and decomposed in the mitochondria to extract energy. Among fatty acids, medium-chain fatty acids can pass through the mitochondrial membrane without the involvement of other components, but long-chain fatty acids cannot pass through the mitochondrial membrane alone.
Ingredients that have the effect of promoting the uptake of fatty acids include ingredients that have the effect of promoting the uptake of fatty acids into cells, and ingredients that have the effect of transporting fatty acids that have been taken up into cells into the mitochondrial membrane or the effect of permeabilizing the mitochondrial membrane.
脂肪酸の細胞内への取り込みを促進する作用を有する成分としては、バチルス/ダイズ発酵エキスが挙げられる。脂肪酸をミトコンドリア内に運搬させる作用又はミトコンドリア膜を透過させる作用を有する成分としては、L-カルニチン、その塩(酒石酸塩、フマル酸塩、塩酸塩など)、又はその誘導体(酢酸、パルミチン酸のような脂肪酸とのエステルなど)、アスタキサンチン、カンカ(カンカニクジュヨウ)エキスが挙げられる。中でも、L-カルニチンが好ましい。
脂肪酸の取り込み促進作用を有する成分は、1種を単独で、又は2種以上を組み合わせて使用できる。
Examples of ingredients that have the effect of promoting the uptake of fatty acids into cells include Bacillus/soybean fermentation extract. Examples of ingredients that have the effect of transporting fatty acids into mitochondria or permeabilizing the mitochondrial membrane include L-carnitine, its salts (tartrates, fumarates, hydrochlorides, etc.), or its derivatives (esters with fatty acids such as acetate and palmitic acid, etc.), astaxanthin, and Cistanche Tubulosa (Cistanche Tubulosa) extract. Among these, L-carnitine is preferred.
The component having the effect of promoting the uptake of fatty acids may be used alone or in combination of two or more.
本発明の皮膚外用剤が(A2)成分(特に、L-カルニチン)を含む場合のその含有量は、皮膚外用剤の全量に対して、0.0001重量%以上が好ましく、0.001重量%以上がより好ましく、0.005重量%以上がさらにより好ましい。また、10重量%以下が好ましく、5重量%以下がより好ましく、1重量%以下がさらにより好ましい。この含有量は、植物抽出物については、乾燥重量に換算した重量から算出した値である。この範囲であれば、(B)成分と共に作用して、十分に運動効果を持続又は向上させることができる。 When the topical skin preparation of the present invention contains component (A2) (particularly L-carnitine), its content is preferably 0.0001% by weight or more, more preferably 0.001% by weight or more, and even more preferably 0.005% by weight or more, based on the total amount of the topical skin preparation. Also, it is preferably 10% by weight or less, more preferably 5% by weight or less, and even more preferably 1% by weight or less. In the case of plant extracts, this content is a value calculated from the weight converted to dry weight. If it is within this range, it can act together with component (B) to sufficiently maintain or improve the exercise effect.
(A3)ミトコンドリア内での脂肪酸の燃焼を促進する作用を有する成分
上記の通り、細胞内に取り込まれた脂肪酸は、ミトコンドリア内でβ-酸化を受けてアセチルCoAとなり、さらにクエン酸回路で二酸化炭素にまで分解され、電子伝達系を経てエネルギーが取り出される。本発明において、ミトコンドリア内での脂肪酸の燃焼を促進する成分は、脂肪酸のβ-酸化、クエン酸回路、電子伝達系の何れの段階の反応を促進するものであってもよい。
このような成分として、アブラナ科植物(中でも、レピジウムメイエニ(マカ)などのマメグンバイナズナ属植物)の抽出物(特に、根又は葉の抽出物)、茶葉抽出物、高麗人参抽出物、アシタバ抽出物、リンゴ酸、ケトオクタデカジエン酸、バチルス/ダイズ発酵エキスなどが挙げられる。中でも、アブラナ科植物(中でも、レピジウムメイエニ(マカ)などのマメグンバイナズナ属植物)の抽出物(特に、根又は葉の抽出物)が好ましい。
レピジウムメイエニ(マカ)抽出物を含有する製品として、マカライン(エクスパンサイエンス社)が挙げられる。
ミトコンドリア内での脂肪酸の燃焼を促進する成分は、1種を単独で、又は2種以上を組み合わせて使用できる。
(A3) Component having the effect of promoting fatty acid combustion in mitochondria As described above, fatty acids taken up into cells undergo β-oxidation in mitochondria to become acetyl CoA, which is further decomposed to carbon dioxide in the citric acid cycle, and energy is extracted via the electron transport system. In the present invention, the component promoting fatty acid combustion in mitochondria may be one that promotes any stage of the reaction in the β-oxidation of fatty acids, the citric acid cycle, or the electron transport system.
Such ingredients include extracts (particularly root or leaf extracts) of Brassicaceae plants (particularly, plants of the genus Columbine such as Lepidium meyenii (Maca)), tea leaf extracts, ginseng extracts, Angelica keiskei extracts, malic acid, ketooctadecadienoic acid, Bacillus/soybean fermentation extracts, etc. Among these, extracts (particularly root or leaf extracts) of Brassicaceae plants (particularly, plants of the genus Columbine such as Lepidium meyenii (Maca)) are preferred.
Products containing Lepidium meyenii (Maca) extract include Macaline (ExpanScience).
The components that promote the combustion of fatty acids in mitochondria can be used alone or in combination of two or more.
本発明の皮膚外用剤が(A3)成分(特に、レピジウムメイエニなどのアブラナ科植物抽出物)を含む場合のその含有量は、皮膚外用剤の全量に対して、0.00001重量%以上が好ましく、0.0001重量%以上がより好ましく、0.0005重量%以上がさらにより好ましい。また、10重量%以下が好ましく、1重量%以下がより好ましく、0.1重量%以下がさらにより好ましい。この含有量は、植物抽出物については、乾燥重量に換算した重量から算出した値である。この範囲であれば、この範囲であれば、(B)成分と共に作用して、十分に運動効果を持続又は向上させることができる。 When the skin topical preparation of the present invention contains the (A3) component (particularly an extract of a Brassicaceae plant such as Lepidium meyenii), the content of the component is preferably 0.00001% by weight or more, more preferably 0.0001% by weight or more, and even more preferably 0.0005% by weight or more, based on the total amount of the skin topical preparation. Also, the content is preferably 10% by weight or less, more preferably 1% by weight or less, and even more preferably 0.1% by weight or less. For plant extracts, this content is a value calculated from the weight converted to dry weight. If it is within this range, it can act together with the (B) component to sufficiently maintain or improve the exercise effect.
本発明の皮膚外用剤の(A)成分の総含有量は、皮膚外用剤の全量に対して、0.0002重量%以上が好ましく、0.002重量%以上がより好ましく、0.006重量%以上がさらにより好ましい。0.01重量%以上とすることもできる。また、10重量%以下が好ましく、5重量%以下がより好ましく、1重量%以下がさらにより好ましい。0.3重量%以下とすることもできる。この含有量は、植物抽出物については、乾燥重量に換算した重量から算出した値である。この範囲であれば、(B)成分と共に作用して、十分に運動効果を持続又は向上させることができる。 The total content of component (A) in the topical skin preparation of the present invention is preferably 0.0002% by weight or more, more preferably 0.002% by weight or more, and even more preferably 0.006% by weight or more, based on the total amount of the topical skin preparation. It can also be 0.01% by weight or more. It is also preferably 10% by weight or less, more preferably 5% by weight or less, and even more preferably 1% by weight or less. It can also be 0.3% by weight or less. For plant extracts, this content is a value calculated from the weight converted to dry weight. If it is within this range, it can act together with component (B) to sufficiently maintain or improve the exercise effect.
(B)発汗を促進する成分
発汗を促進する成分としては、タンブリッサトリコフィラ(Tambourissa trichophylla)(特に、葉)の抽出物、キク科植物(中でも、フキなどのフキ属植物(特に、葉、茎、根)、カミツレ(カモミール、ジャーマンカモミール、ローマカモミールとも称される)などのシカギク属植物(特に、花))の抽出物のような発汗作用と保湿作用を併せ持つ成分が挙げられる。また、石菖(特に、根)の抽出物、トウガラシ(特に、果実)の抽出物、ショウガ(特に、根茎)の抽出物なども挙げられる。
発汗を促進する成分は、1種を単独で、又は2種以上を組み合わせて使用できる。
(B) Components that promote perspiration Examples of components that promote perspiration include components that have both perspiration-inducing and moisturizing effects, such as extracts of Tambourissa trichophylla (particularly leaves), extracts of plants of the Asteraceae family (particularly butterbur plants (particularly leaves, stems, and roots), and plants of the Deer family (particularly flowers) such as chamomile (also called chamomile, German chamomile, or Roman chamomile)). Other examples include extracts of Araceae (particularly roots), extracts of Capsicum anguicum (particularly fruits), and extracts of ginger (particularly rhizomes).
The components that promote sweating may be used alone or in combination of two or more.
中でも、発汗作用と保湿作用の両方を有する成分が好ましく、タンブリッサトリコフィラの抽出物、キク科植物(中でも、フキなどのフキ属植物、カミツレなどのシカギク属植物)の抽出物がより好ましい。
タンブリッサトリコフィラは、マダガスカル島及びコモロス諸島に生息する樹木であり、マダガスカル島ではアンボラーサ又はアンボラと呼ばれて、創傷治癒などに古くから用いられている。タンブリッサトリコフィラ葉抽出物を含有する製品として、アンボラエキス(Bayer Sante Familliale社)が挙げられる。
フキ抽出物を含有する製品として、フキエキス-WSPC、フキエキス-PC、フキエキス-LC(オリザ油化社)、NBA Butter Bur Extract(Arch Personal Care社)が挙げられる。
カミツレ抽出物として、カミツレ抽出液、カミツレ抽出液BG-J、カミツレ抽出液LA(丸善製薬社、イワセコスファ社)、カミツレ抽出液LS、油溶性カミツレ抽出液M、油溶性カミツレ抽出液P(香栄興業社)が挙げられる。この他、カミツレ抽出物は、カモミラエキス、カミツレ水、ローマカミツレ油、ローマカミツレ花油などの名称で市販されており、利用可能である。
Among these, ingredients having both sweat-inducing and moisturizing effects are preferred, and extracts of Tambourissa trichophylla and Asteraceae plants (particularly, butterbur and other butterbur plants, and Deer Daisy and other chamomile plants) are more preferred.
Tambourissa trichophylla is a tree that grows in Madagascar and the Comoros Islands, where it is called Amborasa or Ambora and has been used for wound healing, etc. An example of a product containing Tambourissa trichophylla leaf extract is Ambora Extract (Bayer Sante Familliale).
Products containing butterbur extract include Butterbur Extract-WSPC, Butterbur Extract-PC, and Butterbur Extract-LC (Oryza Oil & Fat Chemical Co., Ltd.), and NBA Butter Bur Extract (Arch Personal Care Co., Ltd.).
Examples of chamomile extracts include chamomile extract, chamomile extract BG-J, chamomile extract LA (Maruzen Pharmaceutical Co., Ltd., Iwase Cosfa Co., Ltd.), chamomile extract LS, oil-soluble chamomile extract M, and oil-soluble chamomile extract P (Koei Kogyo Co., Ltd.). In addition, chamomile extracts are commercially available under names such as chamomile extract, chamomile water, Roman chamomile oil, and Roman chamomile flower oil, and can be used.
本発明の皮膚外用剤の(B)成分の総含有量は、皮膚外用剤の全量に対して、0.0001重量%以上が好ましく、0.001重量%以上がより好ましく、0.005重量%以上がさらにより好ましい。0.01重量%以上とすることもできる。また、10重量%以下が好ましく、5重量%以下がより好ましく、3重量%以下がさらにより好ましい。1重量%以下とすることもできる。この含有量は、植物抽出物については、乾燥重量に換算した重量から算出した値である。この範囲であれば、(A)成分と共に作用して、十分に運動効果を持続又は向上させることができる。 The total content of component (B) in the topical skin preparation of the present invention is preferably 0.0001% by weight or more, more preferably 0.001% by weight or more, and even more preferably 0.005% by weight or more, based on the total amount of the topical skin preparation. It can also be 0.01% by weight or more. It is also preferably 10% by weight or less, more preferably 5% by weight or less, and even more preferably 3% by weight or less. It can also be 1% by weight or less. For plant extracts, this content is a value calculated from the weight converted to dry weight. If it is within this range, it can act together with component (A) to sufficiently maintain or improve the exercise effect.
本発明の皮膚外用剤がタンブリッサトリコフィラの抽出物を含む場合のその含有量は、乾燥重量に換算して、皮膚外用剤の全量に対して、0.00001重量%以上が好ましく、0.0001重量%以上がより好ましい。また、10重量%以下が好ましく、5重量%以下がより好ましく、1重量%以下がさらにより好ましい。この範囲であれば、(A)成分と共に作用して、十分に運動効果を持続又は向上させることができる。
本発明の皮膚外用剤がフキなどのフキ属植物の抽出物を含む場合のその含有量は、乾燥重量に換算して、皮膚外用剤の全量に対して、0.0001重量%以上が好ましく、0.001重量%以上がより好ましい。また、10重量%以下が好ましく、5重量%以下がより好ましい。この範囲であれば、(A)成分と共に作用して、十分に運動効果を持続又は向上させることができる。
本発明の皮膚外用剤がカミツレなどのシカギク属植物の抽出物を含む場合のその含有量は、乾燥重量に換算して、皮膚外用剤の全量に対して、0.0001重量%以上が好ましく、0.001重量%以上がより好ましい。また、10重量%以下が好ましく、5重量%以下がより好ましい。この範囲であれば、(A)成分と共に作用して、十分に運動効果を持続又は向上させることができる。
When the skin external preparation of the present invention contains the extract of Tambourissa trichophylla, its content is preferably 0.00001% by weight or more, more preferably 0.0001% by weight or more, based on the total amount of the skin external preparation, calculated as dry weight.Moreover, it is preferably 10% by weight or less, more preferably 5% by weight or less, and even more preferably 1% by weight or less.Within this range, it can act together with the (A) component to sufficiently maintain or improve the exercise effect.
When the skin external preparation of the present invention contains the extract of butterbur or other butterbur plants, its content is preferably 0.0001% by weight or more, more preferably 0.001% by weight or more, based on the total amount of the skin external preparation, calculated as dry weight. Also, it is preferably 10% by weight or less, more preferably 5% by weight or less. Within this range, it can act together with the (A) component to sufficiently maintain or improve the exercise effect.
When the skin external preparation of the present invention contains the extract of the plant of the genus Deer, such as Chamomile, its content is preferably 0.0001% by weight or more, more preferably 0.001% by weight or more, based on the total amount of the skin external preparation, calculated as dry weight.Moreover, it is preferably 10% by weight or less, more preferably 5% by weight or less.Within this range, it can act together with the (A) component to sufficiently maintain or improve the exercise effect.
(A)成分の総含有量1重量部に対する(B)成分の総含有量の比率は、0.0001重量部以上が好ましく、0.001重量部以上がより好ましく、0.01重量部以上がさらにより好ましい。0.1重量部以上とすることもできる。また、1000重量部以下が好ましく、100重量部以下がより好ましく、10重量部以下がさらにより好ましい。1重量部以下とすることもできる。この含有量は、植物抽出物については、乾燥重量に換算した重量から算出した値である。この範囲であれば、十分に運動効果を持続又は向上させることができる。 The ratio of the total content of the (B) component to 1 part by weight of the total content of the (A) component is preferably 0.0001 parts by weight or more, more preferably 0.001 parts by weight or more, and even more preferably 0.01 parts by weight or more. It can also be 0.1 parts by weight or more. It is also preferably 1000 parts by weight or less, more preferably 100 parts by weight or less, and even more preferably 10 parts by weight or less. It can also be 1 part by weight or less. For plant extracts, this content is a value calculated from the weight converted to dry weight. Within this range, the exercise effect can be sufficiently maintained or improved.
本発明において、植物の抽出物は、特に言及しない限り、葉、茎、花、果実、根、根茎などの何れの抽出物であってもよく、全草の抽出物であってもよい。 In the present invention, unless otherwise specified, the plant extract may be an extract of any part of the plant, such as leaves, stems, flowers, fruits, roots, or rhizomes, or may be an extract of the whole plant.
抽出に用いる溶媒としては、水;塩化ナトリウム、塩化カリウム、塩化マグネシウム、炭酸アンモニウムのような無機塩の水溶液;リン酸緩衝液、酢酸緩衝液、トリス-塩酸緩衝液、炭酸緩衝液、ホウ酸緩衝液のような緩衝液;塩酸、炭酸、硫酸、硝酸、リン酸のような無機酸の水溶液;酢酸、クエン酸、乳酸、コハク酸、アスコルビン酸、フマル酸、リンゴ酸のような有機酸の水溶液;サポニン、レシチンのような界面活性剤の水溶液;メタノール、エタノール、プロパノール、ブタノールのような低級アルコール;アセトン、エチルメチルケトンのようなケトン類などの親水性溶媒ないしは極性溶媒が挙げられる。
また、プロパン、ブタン、ヘキサン、シクロヘキサンのような炭化水素;グリセリン;ジエチルエーテルのようなエーテル;プロピレングリコールのようなグリコール;ジクロロメタン、1,1,1,2-テトラフルオロエタン、1,1,2-トリクロロエテンのようなハロゲン化炭化水素;酢酸エチル、酢酸メチルのような酢酸エステルなどの疎水性溶媒も挙げられる。
溶媒は、1種を単独で、又は2種以上を組み合わせて使用できる。
Solvents used for extraction include hydrophilic or polar solvents such as water; aqueous solutions of inorganic salts such as sodium chloride, potassium chloride, magnesium chloride, and ammonium carbonate; buffer solutions such as phosphate buffer, acetate buffer, Tris-HCl buffer, carbonate buffer, and borate buffer; aqueous solutions of inorganic acids such as hydrochloric acid, carbonic acid, sulfuric acid, nitric acid, and phosphoric acid; aqueous solutions of organic acids such as acetic acid, citric acid, lactic acid, succinic acid, ascorbic acid, fumaric acid, and malic acid; aqueous solutions of surfactants such as saponin and lecithin; lower alcohols such as methanol, ethanol, propanol, and butanol; and ketones such as acetone and ethyl methyl ketone.
Other examples include hydrophobic solvents such as hydrocarbons such as propane, butane, hexane, and cyclohexane; glycerin; ethers such as diethyl ether; glycols such as propylene glycol; halogenated hydrocarbons such as dichloromethane, 1,1,1,2-tetrafluoroethane, and 1,1,2-trichloroethene; and acetates such as ethyl acetate and methyl acetate.
The solvents may be used alone or in combination of two or more.
抽出温度は、適宜設定できるが、例えば4~130℃、中でも20~100℃とすることができる。また、室温で行うこともできる。
抽出物は、液状(流動状、粘液状などを含む)の状態で用いることもでき、或いは、乾燥して、固形状(半固形状、ゲル状などを含む)、例えば粉状にしたものを用いることもできる。
The extraction temperature can be appropriately set, for example, at 4 to 130° C., and preferably at 20 to 100° C. The extraction can also be performed at room temperature.
The extract may be used in a liquid state (including fluid, viscous, etc.) or may be dried and used in a solid state (including semi-solid, gel, etc.), for example in powder form.
(C)温感成分
本発明の皮膚外用剤は、さらに(C)温感成分を含むことができる。
温感成分としては、バニリルブチルエーテルに代表されるバニリルエーテル類や、ノナン酸バニリルアミド、カプサイシンに代表されるバニリルアミド類などの、バニリル基を有する化合物が挙げられるが、本発明の効果を効果的に奏するという観点で、バニリルエーテル類が好ましく、バニリルブチルエーテルがより好ましい。
温感成分は、本発明の(A)成分、(B)成分と共に作用して、顕著に又は相乗的に、運動効果を持続又は向上させることができる。
(C) Warming component The skin topical preparation of the present invention may further contain (C) a warming component.
Examples of warming sensation components include compounds having a vanillyl group, such as vanillyl ethers represented by vanillyl butyl ether, vanillyl amide nonanoate, and vanillyl amides represented by capsaicin. From the viewpoint of effectively exerting the effects of the present invention, vanillyl ethers are preferred, and vanillyl butyl ether is more preferred.
The warming component acts together with the components (A) and (B) of the present invention to significantly or synergistically sustain or improve the exercise effect.
(D)香料
本発明の皮膚外用剤は、さらに香料を含むことができ、これにより、汗などの臭いがマスキングされ、また一層効果的に運動効果を持続又は向上させる場合もある。
香料としては、精油が好ましく、ベルガモット油、ハッカ油、ラベンダー油、ユーカリ油、ローズマリー油、ローズヒップ油、キダチハッカ油、ペパーミント油、スペアミント油、ベチベル油、リトシア・キュベバ油、レモン油、白檀油、ナツメグ油、シナモン油、ヒソップ油、キャラウェー油、オレンジ油、カデ油、グレープフルーツ油、ライム油、サルビア油、タイム油、クローブ油、アロエ油、ジャスミン油、ネロリ油、ローズ油、カンファー油、ゼラニウム油、サンダルウッド油、イランイラン油、メリッサ油、バジル油、パチュリー油、ジュニパー油、ジュニパーベリー油、セージ油、黒コショウ油、マージョラム油、アミリス油、ヨモギ油、ニガヨモギ油、アンゲリカ油、ショウガ油、オールスパイス油、カスカリラ油、カラムス油、クラリセージ油、セロリ油、ティーツリー油、キャロット油、パチョリ油、ベチバー油、ホップ油、マスティック油、ミルラ油、ラブダナム油、ウコン油、オリガナム油、ガランガ油、シトロネラ油、ベイ油、ヤロー油、ピメントベリー油、ロベージ油などが挙げられる。
中でも、ベルガモット油、ユーカリ油が好ましく、ベルガモット油がより好ましい。ベルガモット油の主成分であるリモネン、リナロール、酢酸リナリルも使用することができる。
また、メントール、カンフル、ボルネオール、ゲラニオール、シネオール、アネトール、リモネン、オイゲノールのようなテルペン類(これらはd体、l体又はdl体の何れでもよい。)も好ましい。
(D) Fragrances The skin topical preparation of the present invention may further contain fragrances, which may mask the odor of sweat and the like and may further effectively sustain or improve the effects of exercise.
As the fragrance, essential oils are preferable, and examples thereof include bergamot oil, peppermint oil, lavender oil, eucalyptus oil, rosemary oil, rosehip oil, peppermint oil, spearmint oil, vetiver oil, lithodia cubeba oil, lemon oil, sandalwood oil, nutmeg oil, cinnamon oil, hyssop oil, caraway oil, orange oil, cade oil, grapefruit oil, lime oil, salvia oil, thyme oil, clove oil, aloe oil, jasmine oil, neroli oil, rose oil, camphor oil, geranium oil, sandalwood oil, ylang-ylang oil, medicinal herb, and oleaginous herb. Examples of oils that may be used include lyssa oil, basil oil, patchouli oil, juniper oil, juniper berry oil, sage oil, black pepper oil, marjoram oil, amyris oil, mugwort oil, wormwood oil, angelica oil, ginger oil, allspice oil, cascarilla oil, calamus oil, clary sage oil, celery oil, tea tree oil, carrot oil, patchouli oil, vetiver oil, hops oil, mastic oil, myrrh oil, labdanum oil, turmeric oil, origanum oil, galangal oil, citronella oil, bay oil, yarrow oil, pimento berry oil, and lovage oil.
Among these, bergamot oil and eucalyptus oil are preferred, and bergamot oil is more preferred. Limonene, linalool, and linalyl acetate, which are the main components of bergamot oil, can also be used.
Also preferred are terpenes such as menthol, camphor, borneol, geraniol, cineol, anethole, limonene and eugenol (which may be in any of the d-, l- or dl-forms).
本発明の皮膚外用剤が香料を含む場合のその含有量は、皮膚外用剤の全量に対して、0.0001重量%以上が好ましく、0.001重量%以上がより好ましく、0.01重量%以上がさらにより好ましい。また、5重量%以下が好ましく、1重量%以下がより好ましく、0.5重量%以下がさらにより好ましい。この範囲であれば、マスキング効果が十分に得られ、また香料によっては運動効果を持続又は向上させる。 When the topical skin preparation of the present invention contains a fragrance, the content of the fragrance is preferably 0.0001% by weight or more, more preferably 0.001% by weight or more, and even more preferably 0.01% by weight or more, based on the total amount of the topical skin preparation. Also, the content is preferably 5% by weight or less, more preferably 1% by weight or less, and even more preferably 0.5% by weight or less. Within this range, a sufficient masking effect is obtained, and depending on the fragrance, the exercise effect is maintained or improved.
その他の成分
本発明の皮膚外用剤は、上記(A)成分、(B)成分、場合によっては(C)成分を含む成分を、化粧品、又は医薬部外品に使用される基剤又は担体、及び必要に応じて添加剤や、その他の生理活性又は薬理活性成分と混合して、化粧品、又は医薬部外品の皮膚外用剤とすることができる。
Other Components The topical skin preparation of the present invention can be prepared as a cosmetic or quasi-drug topical skin preparation by mixing the above-mentioned components (A), (B), and optionally (C) with a base or carrier used in cosmetics or quasi-drugs, and, if necessary, with additives and other physiologically active or pharmacologically active components.
添加剤としては、例えば、界面活性剤、増粘剤、保存剤、pH調整剤、安定化剤又はキレート剤、紫外線吸収剤又は紫外線散乱剤、刺激軽減剤、着色剤などが挙げられる。
添加剤は、1種を単独で、又は2種以上を組み合わせて使用できる。
また、添加剤は、本発明の効果を損なわない範囲で使用することができる。
Examples of additives include surfactants, thickeners, preservatives, pH adjusters, stabilizers or chelating agents, ultraviolet absorbing agents or ultraviolet scattering agents, irritation reducing agents, and colorants.
The additives may be used alone or in combination of two or more.
Moreover, additives can be used within a range that does not impair the effects of the present invention.
界面活性剤としては、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテート、ソルビタンモノステアレート、ソルビタンセスキオレート、ペンタ-2-エチルヘキシル酸ジグリセロールソルビタン、テトラ-2-エチルヘキシル酸ジグリセロールソルビタン等のソルビタン脂肪酸エステル類、モノステアリン酸グリセリン、モノステアリン酸グリセリンリンゴ酸等のグリセリン脂肪酸類、モノイソステアリン酸ポリグリセリル、ジイソステアリン酸ポリグリセリル等のポリグリセリン脂肪酸類、モノステアリン酸プロピレングリコール等のプロピレングリコール脂肪酸エステル類、ポリオキシエチレン硬化ヒマシ油(ポリオキシエチレン硬化ヒマシ油40、ポリオキシエチレン硬化ヒマシ油60、ポリオキシエチレン硬化ヒマシ油80など)等の硬化ヒマシ油誘導体、モノラウリル酸ポリオキシエチレン(20)ソルビタン(ポリソルベート20)、モノステアリン酸ポリオキシエチレン(20)ソルビタン(ポリソルベート60)、モノオレイン酸ポリオキシエチレン(20)ソルビタン(ポリソルベート80)等のポリオキシエチレンソルビタン脂肪酸エステル類、ポリオキシエチレンモノヤシ油脂肪酸グリセリル、グリセリンアルキルエーテル、アルキルグルコシド、ポリオキシエチレンセチルエーテル(セトマクロゴール)、ステアリルアミン、オレイルアミンなどが挙げられる。 Surfactants include sorbitan fatty acid esters such as sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate, diglycerol sorbitan penta-2-ethylhexyl acid, and diglycerol sorbitan tetra-2-ethylhexyl acid, glycerin fatty acids such as glycerin monostearate and glycerin monostearate malate, polyglycerin fatty acids such as polyglyceryl monoisostearate and polyglyceryl diisostearate, propylene glycol fatty acid esters such as propylene glycol monostearate, and polyoxyethylene hydrogenated castor oil (polyoxyethylene hydrogenated castor oil). Examples of such derivatives include hydrogenated castor oil derivatives such as polyoxyethylene hydrogenated castor oil 40, polyoxyethylene hydrogenated castor oil 60, and polyoxyethylene hydrogenated castor oil 80; polyoxyethylene sorbitan fatty acid esters such as polyoxyethylene (20) sorbitan monolaurate (polysorbate 20), polyoxyethylene (20) sorbitan monostearate (polysorbate 60), and polyoxyethylene (20) sorbitan monooleate (polysorbate 80); polyoxyethylene monococoate glyceryl, glycerin alkyl ether, alkyl glucoside, polyoxyethylene cetyl ether (cetomacrogol), stearylamine, and oleylamine.
増粘剤としては、増粘多糖類(グアーガム、ローカストビーンガム、カラギーナン、キサンタンガム、デキストランなど)、セルロース系増粘剤(メチルセルロース、エチルセルロース、カルボキシメチルセルロース、カルボキシエチルセルロース、ヒドロキシメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロースなど)、アルギン酸、その塩、及びその誘導体(アルギン酸、アルギン酸ナトリウム、アルギン酸プロピレングリコールエステルなど)、ビニル系増粘剤(ポリビニルアルコール、ポリビニルピロリドン、ポリビニルメチルエーテル、カルボキシビニルポリマー、アクリル酸メタクリル酸アルキル共重合体、ポリアクリル酸ナトリウムなど)、ベントナイト、デキストリン脂肪酸エステル、ペクチンなどが挙げられる。 Thickening agents include thickening polysaccharides (guar gum, locust bean gum, carrageenan, xanthan gum, dextran, etc.), cellulose-based thickening agents (methylcellulose, ethylcellulose, carboxymethylcellulose, carboxyethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, etc.), alginic acid, its salts and its derivatives (alginic acid, sodium alginate, propylene glycol alginate, etc.), vinyl-based thickening agents (polyvinyl alcohol, polyvinylpyrrolidone, polyvinyl methyl ether, carboxyvinyl polymer, acrylic acid/alkyl methacrylate copolymer, sodium polyacrylate, etc.), bentonite, dextrin fatty acid ester, pectin, etc.
保存剤としては、安息香酸、安息香酸ナトリウム、デヒドロ酢酸、デヒドロ酢酸ナトリウム、パラオキシ安息香酸イソブチル、パラオキシ安息香酸イソプロピル、パラオキシ安息香酸ブチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ベンジル、パラオキシ安息香酸メチル、フェノキシエタノール、BHTなどが挙げられる。 Preservatives include benzoic acid, sodium benzoate, dehydroacetic acid, sodium dehydroacetate, isobutyl parahydroxybenzoate, isopropyl parahydroxybenzoate, butyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, benzyl parahydroxybenzoate, methyl parahydroxybenzoate, phenoxyethanol, and BHT.
pH調整剤としては、無機酸(塩酸、硫酸、リン酸、ポリリン酸、ホウ酸など)、有機酸(乳酸、酢酸、クエン酸、酒石酸、リンゴ酸、コハク酸、コハク酸ナトリウム、シュウ酸、グルコン酸、フマル酸、プロピオン酸、酢酸、アスパラギン酸、イプシロン-アミノカプロン酸、グルタミン酸、アミノエチルスルホン酸など)、グルコノラクトン、酢酸アンモニウム、無機塩基(炭酸水素ナトリウム、炭酸ナトリウム、水酸化カリウム、水酸化ナトリウム、水酸化カルシウム、水酸化マグネシウムなど)、有機塩基(モノエタノールアミン、トリエタノールアミン、ジイソプロパノールアミン、トリイソプロパノールアミン、リジンなど)などが挙げられる。 Examples of pH adjusters include inorganic acids (hydrochloric acid, sulfuric acid, phosphoric acid, polyphosphoric acid, boric acid, etc.), organic acids (lactic acid, acetic acid, citric acid, tartaric acid, malic acid, succinic acid, sodium succinate, oxalic acid, gluconic acid, fumaric acid, propionic acid, acetic acid, aspartic acid, epsilon-aminocaproic acid, glutamic acid, aminoethylsulfonic acid, etc.), gluconolactone, ammonium acetate, inorganic bases (sodium bicarbonate, sodium carbonate, potassium hydroxide, sodium hydroxide, calcium hydroxide, magnesium hydroxide, etc.), and organic bases (monoethanolamine, triethanolamine, diisopropanolamine, triisopropanolamine, lysine, etc.).
安定化剤又はキレート剤としては、エデト酸ナトリウム、エデト酸四ナトリウム、エデト酸四ナトリウム四水塩などが挙げられる。 Examples of stabilizers or chelating agents include sodium edetate, tetrasodium edetate, and tetrasodium edetate tetrahydrate.
紫外線吸収剤又は紫外線散乱剤としては、パラメトキシケイ皮酸2-エチルヘキシル、2-[4-(ジエチルアミノ)-2-ヒドロキシベンゾイル]安息香酸ヘキシルエステル、2,4,6-トリス[4-(2-エチルヘキシルオキシカルボニル)アニリノ)-1,3,5-トリアジン、t-ブチルメトキシジベンゾイルメタン、ジベンジリデンジオキソイミダゾリジンプロピロン酸エチルヘキシル、エトルヘキシルトリアゾリン、パラアミノ安息香酸およびその誘導体、パラジメチルアミノ安息香酸オクチル、サリチル酸エチレングリコール、ジヒドロキシベンゾフェノン、酸化チタン、酸化亜鉛などが挙げられる。 Examples of ultraviolet absorbing agents or ultraviolet scattering agents include 2-ethylhexyl paramethoxycinnamate, 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoic acid hexyl ester, 2,4,6-tris[4-(2-ethylhexyloxycarbonyl)anilino)-1,3,5-triazine, t-butylmethoxydibenzoylmethane, ethylhexyl dibenzylidene dioxoimidazolidine propylonate, ethylhexyl triazoline, paraaminobenzoic acid and its derivatives, octyl paradimethylaminobenzoate, ethylene glycol salicylate, dihydroxybenzophenone, titanium oxide, and zinc oxide.
刺激軽減剤としては、甘草エキス、アルギン酸ナトリウムなどが挙げられる。 Irritation reducing agents include licorice extract and sodium alginate.
着色料としては、法定色素ハンドブック(日本化粧品工業連合会編(2004))に記載された色素などが挙げられる。 Coloring agents include those listed in the Legal Dye Handbook (edited by the Japan Cosmetic Industry Association (2004)).
その他の生理活性又は薬理活性成分としては、例えば、保湿成分、ビタミン類、ペプチド又はその誘導体、血行促進成分、細胞賦活化成分、老化防止成分、美白成分、アミノ酸、タンパク質、植物エキス((A)成分及び(B)成分を除く)などが挙げられる。
その他の生理活性又は薬理活性成分は、1種を単独で、又は2種以上を組み合わせて使用できる。
また、その他の生理活性又は薬理活性成分は、本発明の効果を損なわない範囲で使用することができる。
Other physiologically or pharmacologically active ingredients include, for example, moisturizing ingredients, vitamins, peptides or derivatives thereof, blood circulation promoting ingredients, cell activating ingredients, anti-aging ingredients, whitening ingredients, amino acids, proteins, plant extracts (excluding component (A) and component (B)), etc.
The other physiologically or pharmacologically active ingredients may be used alone or in combination of two or more.
In addition, other physiologically or pharmacologically active ingredients can be used within the scope that does not impair the effects of the present invention.
保湿成分としては、グリセリン、ジプロピレングリコール、1,3-ブチレングリコール、プロピレングリコール、ポリエチレングリコール、ジグリセリン、ペンタンジオール、ヘキサンジオール、オクタンジオールのような多価アルコール、トレハロース、キシリトール、ソルビトールのような糖類、ヒアルロン酸ナトリウム、ヘパリン類似物質、コンドロイチン硫酸ナトリウム、ケラチン、キチン、キトサンのような高分子化合物、セラミド、コレステロール、リン脂質のような脂質、ハマメリスエキス、チャエキスのような植物抽出物などが挙げられる。 Moisturizing ingredients include polyhydric alcohols such as glycerin, dipropylene glycol, 1,3-butylene glycol, propylene glycol, polyethylene glycol, diglycerin, pentanediol, hexanediol, and octanediol; sugars such as trehalose, xylitol, and sorbitol; polymeric compounds such as sodium hyaluronate, heparinoids, sodium chondroitin sulfate, keratin, chitin, and chitosan; lipids such as ceramide, cholesterol, and phospholipids; and plant extracts such as witch hazel extract and tea extract.
ビタミン類としては、dl-α-トコフェロール、酢酸dl-α-トコフェロール、コハク酸dl-α-トコフェロール、コハク酸dl-α-トコフェロールカルシウム等のビタミンE類、ユビキノン誘導体及びその薬学的又は生理学的に許容される塩、リボフラビン、フラビンモノヌクレオチド、フラビンアデニンジヌクレオチド、リボフラビン酪酸エステル、リボフラビンテトラ酪酸エステル、リボフラビン5’-リン酸エステルナトリウム、リボフラビンテトラニコチン酸エステル、ニコチン酸dl-α-トコフェロール、ニコチン酸ベンジル、ニコチン酸メチル、ニコチン酸β-ブトキシエチル、ニコチン酸1-(4-メチルフェニル)エチル、アスコルビゲン-A、アスコルビン酸ステアリン酸エステル、アスコルビン酸パルミチン酸エステル、ジパルミチン酸L-アスコルビル、メチルヘスペリジン、エルゴカルシフェロール、コレカルシフェロール、フィロキノン、ファルノキノン、γ-オリザノール、ジベンゾイルチアミン、ジベンゾイルチアミン塩酸塩、チアミン塩酸塩、チアミンセチル塩酸塩、チアミンチオシアン酸塩、チアミンラウリル塩酸塩、チアミン硝酸塩、チアミンモノリン酸塩、チアミンリジン塩、チアミントリリン酸塩、チアミンモノリン酸エステルリン酸塩、チアミンモノリン酸エステル、チアミンジリン酸エステル、チアミンジリン酸エステル塩酸塩、チアミントリリン酸エステル、チアミントリリン酸エステルモノリン酸塩、塩酸ピリドキシン、酢酸ピリドキシン、塩酸ピリドキサール、5’-リン酸ピリドキサール、塩酸ピリドキサミン、シアノコバラミン、ヒドロキソコバラミン、デオキシアデノシルコバラミン、葉酸、プテロイルグルタミン酸、ニコチン酸、ニコチン酸アミド、パントテン酸、パントテン酸カルシウム、パントテニルアルコール(パンテノール)、D-パンテサイン、D-パンテチン、補酵素A、パントテニルエチルエーテル等のパントテン酸類、ビオチン、ビオチシン、アスコルビン酸、アスコルビン酸ナトリウム、デヒドロアスコルビン酸、アスコルビン酸リン酸エステルナトリウム、アスコルビン酸リン酸エステルマグネシウム、カルニチン、フェルラ酸、α-リポ酸、オロット酸、ヘスペリジン、γ-オリザノール、オロチン酸、ルチン、エリオシトリン及びその薬学的又は生理学的に許容される塩などが挙げられる。 Vitamins include vitamin E such as dl-α-tocopherol, dl-α-tocopherol acetate, dl-α-tocopherol succinate, and dl-α-tocopherol calcium succinate, ubiquinone derivatives and their pharma- ceutical or physiologically acceptable salts, riboflavin, flavin mononucleotide, flavin adenine dinucleotide, riboflavin butyrate, riboflavin tetrabutyrate, riboflavin 5'-phosphate sodium, riboflavin tetranicotinate, dl-α-tocopherol nicotinate, and benzyl nicotinate. , methyl nicotinate, β-butoxyethyl nicotinate, 1-(4-methylphenyl)ethyl nicotinate, ascorbigen-A, ascorbyl stearate, ascorbyl palmitate, L-ascorbyl dipalmitate, methylhesperidin, ergocalciferol, cholecalciferol, phylloquinone, farnoquinone, gamma-oryzanol, dibenzoyl thiamine, dibenzoyl thiamine hydrochloride, thiamine hydrochloride, thiamine cetyl hydrochloride, thiamine thiocyanate, thiamine lauryl hydrochloride, thiamine nitrate, thiamine mono ... Thiamine phosphate, thiamine lysine salt, thiamine triphosphate, thiamine monophosphate phosphate, thiamine monophosphate, thiamine diphosphate, thiamine diphosphate hydrochloride, thiamine triphosphate, thiamine triphosphate monophosphate, pyridoxine hydrochloride, pyridoxine acetate, pyridoxal hydrochloride, pyridoxal 5'-phosphate, pyridoxamine hydrochloride, cyanocobalamin, hydroxocobalamin, deoxyadenosylcobalamin, folic acid, pteroylglutamic acid, nicotinic acid, nicotinamide, pantothenic acid, pantothenic acid, Examples of such pantothenic acids include calcium pantothenate, pantothenyl alcohol (panthenol), D-pantethein, D-pantethine, coenzyme A, pantothenyl ethyl ether, etc., biotin, bioticin, ascorbic acid, sodium ascorbate, dehydroascorbic acid, sodium ascorbyl phosphate, magnesium ascorbyl phosphate, carnitine, ferulic acid, α-lipoic acid, orotic acid, hesperidin, γ-oryzanol, orotic acid, rutin, eriocitrin, and pharma- ceutical or physiologically acceptable salts thereof.
ペプチド又はその誘導体としては、ケラチン分解ペプチド、加水分解ケラチン、コラーゲン、ゼラチン、エラスチン、エラスチン分解ペプチド、コラーゲン分解ペプチド、加水分解コラーゲン、加水分解シルクなどが挙げられる。 Examples of peptides or derivatives thereof include keratin decomposition peptides, hydrolyzed keratin, collagen, gelatin, elastin, elastin decomposition peptides, collagen decomposition peptides, hydrolyzed collagen, and hydrolyzed silk.
血行促進成分としては、オタネニンジン、アシタバ、アルニカ、イチョウ、エンメイソウ、オランダカシ、カロット、ゲンチアナ、ゴボウ、コメ、サンザシ、シイタケ、セイヨウサンザシ、セイヨウネズ、センキュウ、センブリ、タイム、チョウジ、チンピ、トウキ、トウニン、トウヒ、ニンジン、ニンニク、ブッチャーブルーム、ブドウ、ボタン、マロニエ、メリッサ、ユズ、ヨクイニン、ローズマリー、ローズヒップ、モモ、アンズ、クルミ、トウモロコシなどの抽出物や、グルコシルヘスペリジン(柑橘類皮抽出物)、セファランチン(タマサキツヅラフジ根抽出物)などが挙げられる。
血行促進成分は、本発明の(A)成分、(B)成分と共に作用して、顕著に又は相乗的に、運動効果を持続又は向上させることができる。
Examples of blood circulation-promoting ingredients include extracts of ginseng, angelica, arnica, ginkgo, Japanese oak, Dutch oak, carrot, gentian, burdock, rice, hawthorn, shiitake mushroom, European hawthorn, European juniper, Cnidium rhizome, Swertia britannica, thyme, clove, Chinese ginger, Angelica acutiloba, Prunus persica, spruce, carrot, garlic, butcher's broom, grape, peony, horse chestnut, melissa, yuzu, coix seed, rosemary, rose hip, peach, apricot, walnut, and corn, as well as glucosyl hesperidin (citrus peel extract) and cepharanthin (Tamasakisazurafuji root extract).
The blood circulation-promoting component acts together with the components (A) and (B) of the present invention to significantly or synergistically sustain or improve the effect of exercise.
細胞賦活成分としては、γ-アミノ酪酸、γ-アミノ-β-ヒドロキシ酪酸、ε-アミノカプロン酸のようなアミノ酸類、レチノール、チアミン、リボフラビン、塩酸ピリドキシン、パントテン酸類、ビオチンのようなビタミン類、グリコール酸、乳酸のようなα-ヒドロキシ酸類、タンニン、フラボノイド、サポニン、アラントイン、感光素301号、胎盤抽出液、ヒノキチオール、セファランチン、キウイ種子抽出物などが挙げられる。 Cell activation ingredients include amino acids such as gamma-aminobutyric acid, gamma-amino-beta-hydroxybutyric acid, and epsilon-aminocaproic acid, vitamins such as retinol, thiamine, riboflavin, pyridoxine hydrochloride, pantothenic acids, and biotin, alpha-hydroxy acids such as glycolic acid and lactic acid, tannins, flavonoids, saponin, allantoin, photosensitizer No. 301, placenta extract, hinokitiol, cepharanthin, and kiwi seed extract.
老化防止成分としては、パンガミン酸、カイネチン、ウルソール酸、ウコンエキス、スフィンゴシン誘導体、ケイ素、ケイ酸、N-メチル-L-セリン、メバロノラクトンなどが挙げられる。 Anti-aging ingredients include pangamic acid, kinetin, ursolic acid, turmeric extract, sphingosine derivatives, silicon, silicic acid, N-methyl-L-serine, and mevalonolactone.
美白成分としては、トコフェロール、アスコルビン酸、トラネキサム酸、アルブチン、4-アルキルレゾルシノール4-メトキシサリチル酸、ハイドロキノン、コウジ酸、それらの塩、又はそれらの誘導体、胎盤抽出物、オウバク抽出物、ユキノシタ抽出物、アロエ抽出物、マテチャ抽出物のような植物抽出物などが挙げられる。 Skin-whitening ingredients include tocopherol, ascorbic acid, tranexamic acid, arbutin, 4-alkylresorcinol, 4-methoxysalicylic acid, hydroquinone, kojic acid, their salts or derivatives, and plant extracts such as placenta extract, Phellodendron bark extract, Saxifraga extract, aloe extract, and Matecha extract.
基剤又は担体
基剤又は担体としては、油性基剤、水性基剤が挙げられる。
油性基剤としては、流動パラフィン、ワセリン、ゲル化炭化水素(プラスチベースなど)、オゾケライト、α-オレフィンオリゴマー、及び軽質流動パラフィンのような炭化水素;メチルポリシロキサン、架橋型メチルポリシロキサン、高重合メチルポリシロキサン、環状シリコーン、アルキル変性シリコーン、架橋型アルキル変性シリコーン、アミノ変性シリコーン、ポリエーテル変性シリコーン、ポリグリセリン変性シリコーン、架橋型ポリエーテル変性シリコーン、架橋型アルキルポリエーテル変性シリコーン、シリコーン・アルキル鎖共変性ポリエーテル変性シリコーン、シリコーン・アルキル鎖共変性ポリグリセリン変性シリコーン、ポリエーテル変性分岐シリコーン、ポリグリセリン変性分岐シリコーン、アクリルシリコン、フェニル変性シリコーン、及びシリコーンレジンのようなシリコーン油;セタノール、セトステアリルアルコール、ステアリルアルコール、及びベヘニルアルコールのような高級アルコール;コレステロール、フィトステロール、及びヒドロキシステアリン酸フィトステリルのようなステロール類;シアバター、カルバナロウ、及びキャンデリラロウのような植物脂;ラノリン、オレンジラフィー油、スクワラン、馬油、鯨ロウ、及びミツロウのような動物油脂;エチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルメチルセルロース、カチオン化グアガム、及びアセチル化ヒアルロン酸のような天然高分子誘導体;ポリビニルピロリドン、カルボキシビニルポリマー、及びアクリル酸メタクリル酸アルキル共重合体のような合成高分子;カラギーナン、アルギン酸、セルロース、キサンタンガム、グアーガム、クインスシード、デキストラン、ジェランガム、及びヒアルロン酸のような天然高分子;ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、パルミチン酸セチル、イソノナン酸イソノニル、テトラ2-エチルヘキサン酸ペンタエリスリット、及びトリ(カプリル酸/カプリン酸)グリセリルのような脂肪酸エステル類;デキストリン、及びマルトデキストリンのような多糖類;エチレングリコールモノメチルエーテル、エチレングリコールモノエチルエーテル、エチレングリコールモノプロピルエーテル、ジエチレングリコールモノメチルエーテル、ジエチレングリコールモノエチルエーテル、ジエチレングリコールモノプロピルエーテル、ジエチレングリコールモノブチルエーテル、プロピレングリコールモノエチルエーテル、プロピレングリコールモノプロピルエーテル、ジプロピレングリコールモノエチルエーテル、及びジプロピレングリコールモノプロピルエーテルのようなグリコールエーテルなどが挙げられる。
また、水性基剤としては、水、緩衝液の他に、エタノール、及びイソプロパノールのような低級アルコール;ポリエチレングリコール、プロピレングリコール、1,3-ブチレングリコール、グリセリン、イソプレングリコール、ジグリセリン、及びジプロピレングリコールのような多価アルコールなどが挙げられる。
基材又は担体は、1種を単独で、又は2種以上を組み合わせて使用できる。
Base or Carrier The base or carrier includes an oily base and an aqueous base.
Examples of oily bases include hydrocarbons such as liquid paraffin, petrolatum, gelling hydrocarbons (such as Plastibase), ozokerite, α-olefin oligomers, and light liquid paraffin; methyl polysiloxane, crosslinked methyl polysiloxane, highly polymerized methyl polysiloxane, cyclic silicone, alkyl-modified silicone, crosslinked alkyl-modified silicone, amino-modified silicone, polyether-modified silicone, polyglycerin-modified silicone, crosslinked polyether-modified silicone, crosslinked alkyl polyether-modified silicone, silicone/alkyl chain co-modified polyether-modified silicone, silicone/alkyl chain co-modified polyglycerin-modified silicone. silicone oils such as polyether-modified branched silicone, polyglycerin-modified branched silicone, acrylic silicone, phenyl-modified silicone, and silicone resin; higher alcohols such as cetanol, cetostearyl alcohol, stearyl alcohol, and behenyl alcohol; sterols such as cholesterol, phytosterol, and phytosteryl hydroxystearate; vegetable fats such as shea butter, carnauba wax, and candelilla wax; animal fats and oils such as lanolin, orange roughy oil, squalane, horse oil, spermaceti, and beeswax; ethyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose natural polymer derivatives such as cellulose, hydroxypropyl methylcellulose, cationic guar gum, and acetylated hyaluronic acid; synthetic polymers such as polyvinylpyrrolidone, carboxyvinyl polymers, and alkyl acrylate/methacrylate copolymers; natural polymers such as carrageenan, alginic acid, cellulose, xanthan gum, guar gum, quince seed, dextran, gellan gum, and hyaluronic acid; isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, cetyl palmitate, isononyl isononanoate, pentaerythritol tetra 2-ethylhexanoate, and tri(caprylic/capric)glycerol. Examples of the fatty acid esters include lyceryl; polysaccharides such as dextrin and maltodextrin; and glycol ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monopropyl ether, diethylene glycol monobutyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, dipropylene glycol monoethyl ether, and dipropylene glycol monopropyl ether.
In addition to water and buffer solutions, aqueous bases include lower alcohols such as ethanol and isopropanol; and polyhydric alcohols such as polyethylene glycol, propylene glycol, 1,3-butylene glycol, glycerin, isoprene glycol, diglycerin, and dipropylene glycol.
The substrate or carrier may be used alone or in combination of two or more.
本発明の皮膚外用剤の製剤形態は特に限定されず、液剤、懸濁剤、乳剤、クリーム剤、軟膏剤、ジェル剤(ゲル剤)、リニメント剤、ローション剤、フォーム剤、スプレー剤、エアゾール剤、パウダー剤、パップ剤、不織布等のシートに薬液を含浸させたシート剤などが挙げられる。中でも、皮膚に塗り伸ばし易く、使用感が良い点で、ローション剤、ジェル剤(ゲル剤)、乳剤、クリーム剤、スプレー剤、エアゾール剤が好ましい。
乳剤、クリーム剤、乳剤性軟膏剤などの乳化状態の剤型である場合は、水中油型又は油中水型の何れでも良いが、使用感が良い点で、水中油型が好ましい。
The formulation of the topical skin preparation of the present invention is not particularly limited, and examples thereof include liquids, suspensions, emulsions, creams, ointments, gels, liniments, lotions, foams, sprays, aerosols, powders, poultices, sheets of nonwoven fabric or the like impregnated with a medicinal liquid, etc. Among these, lotions, gels, emulsions, creams, sprays, and aerosols are preferred because they are easy to spread on the skin and have a good feel when used.
In the case of an emulsified formulation such as an emulsion, cream, or emulsion ointment, it may be either an oil-in-water type or a water-in-oil type, but the oil-in-water type is preferred in terms of better usability.
用途
本発明の皮膚外用剤は、運動の際に皮膚に塗布して、運動により得られる効果を持続又は向上させるために使用できる。具体的には、皮膚又は身体の温度(特に、運動により上昇した皮膚又は身体の温度)の維持又は上昇のため、発汗(特に、運動により増大した発汗)の持続又は増大のため、血流(特に、運動により増大した血流)の維持又は増大のため、爽快状態(特に、運動により高まった爽快状態)の持続又は促進のためなどに使用できる。
本発明の皮膚外用剤を使用すれば、軽い運動であっても、運動効果が持続又は増大するため、しっかり運動したという実感(実効感)が得られる。従って、運動効果持続又は向上は、運動実感の持続又は向上と捉えることもできる。
また、運動効果が持続すると、運動による気持ちの良い体感又は感覚が持続するため、運動効果の持続又は向上は、運動体感又は感覚の持続又は向上と捉えることもできる。具体的には、本発明の皮膚外用剤は、温感(特に、運動により増大した温感)の維持又は向上のため、発汗実感(特に、運動により増大した発汗実感)の維持又は向上のため、血流増大感(特に、運動により上昇した血流増大感)の維持又は向上のため、爽快感(特に、運動により高まった爽快感)の維持又は向上のために使用できる。
The skin topical preparation of the present invention can be applied to the skin during exercise and used to maintain or improve the effects obtained by exercise. Specifically, it can be used to maintain or increase the temperature of the skin or body (particularly, the temperature of the skin or body increased by exercise), to maintain or increase sweating (particularly, sweating increased by exercise), to maintain or increase blood flow (particularly, blood flow increased by exercise), and to maintain or promote a refreshing state (particularly, a refreshing state increased by exercise).
By using the skin external preparation of the present invention, the exercise effect is sustained or increased even in light exercise, so that the user can feel as if they have exercised properly (feeling of effectiveness). Therefore, the sustained or improved exercise effect can also be considered as the sustained or improved feeling of exercise.
Furthermore, when the exercise effect is sustained, the pleasant sensation or feeling caused by exercise is sustained, so the sustained or improved exercise effect can be regarded as the sustained or improved sensation or feeling of exercise. Specifically, the skin topical preparation of the present invention can be used to maintain or improve a sense of warmth (particularly, a sense of warmth increased by exercise), to maintain or improve a sense of sweating (particularly, a sense of sweating increased by exercise), to maintain or improve a sense of increased blood flow (particularly, a sense of increased blood flow increased by exercise), and to maintain or improve a sense of refreshment (particularly, a sense of refreshment increased by exercise).
使用方法
本発明の皮膚外用剤は、運動に際して皮膚に適用すればよい。運動前、運動中、運動後の何れに使用しても良いが、運動中、運動後に使用するのが好ましく、運動後に使用するのがより好ましい。運動前は、運動の前10分以内、中でも5分以内、中でも1分以内とすることができる。また、運動後は、運動の後30分以内、中でも10分以内、中でも5分以内、中でも1分以内、中でも30秒以内とすることができる。運動後は、そのまま塗布しても良く、汗を拭って塗布しても良く、あるいはシャワー等で汗を流してから塗布しても良い。塗布する場合は、軽くなじませるように塗布しても良いが、マッサージしながら塗布するのが好ましい。
また、運動前、運動中、運動後にそれぞれ、1回、又は複数回塗布することができる。
Method of Use The skin external preparation of the present invention may be applied to the skin during exercise. It may be applied before exercise, during exercise, or after exercise, but it is preferable to apply it during exercise or after exercise, and more preferable to apply it after exercise. Before exercise, it can be within 10 minutes, especially within 5 minutes, especially within 1 minute before exercise. After exercise, it can be within 30 minutes, especially within 10 minutes, especially within 5 minutes, especially within 1 minute after exercise, especially within 30 seconds after exercise. After exercise, it may be applied as it is, or it may be applied after wiping off sweat, or it may be applied after washing off sweat with a shower or the like. When applying, it may be applied so as to be lightly blended, but it is preferable to apply it while massaging.
In addition, the composition may be applied once or multiple times before, during, and after exercise.
本発明の皮膚外用剤の使用に適した運動時間は、特に限定されない。例えば、1分間~12時間、3分間~3時間、5分間~2時間、10分間~1時間、20~30分間、10~15分間などの運動時間が挙げられる。 The exercise time suitable for use of the topical skin preparation of the present invention is not particularly limited. For example, the exercise time may be 1 minute to 12 hours, 3 minutes to 3 hours, 5 minutes to 2 hours, 10 minutes to 1 hour, 20 to 30 minutes, or 10 to 15 minutes.
本発明の皮膚外用剤の適用部位は、特に限定されない。首、腕、手、胴体(腹、腰回り、背中、胸、臀部)、足、顔などの皮膚が挙げられる。中でも首、腕、手、胴体(腹、腰回り、背中、胸、臀部)、足、特に腕、手、胴体(腹、腰回り、背中、胸、臀部)、足に適用すれば、運動効果持続又は向上作用が大きくなる。
本発明の皮膚外用剤の使用量は、特に限定されず、皮膚になじむ程度の量であればよい。皮膚の1cm2当たり0.001~0.01g程度が挙げられる。
皮膚への適用方法は、剤型により異なり、塗布、噴霧、貼付などとすることができる。
The application site of the skin topical agent of the present invention is not particularly limited. Examples include the skin of the neck, arms, hands, trunk (abdomen, waist, back, chest, buttocks), legs, face, etc. Among them, application to the neck, arms, hands, trunk (abdomen, waist, back, chest, buttocks), legs, especially the arms, hands, trunk (abdomen, waist, back, chest, buttocks), and legs will have a large effect of sustaining or improving the exercise effect.
The amount of the skin preparation of the present invention to be used is not particularly limited, and may be an amount sufficient for absorption by the skin, such as about 0.001 to 0.01 g per 1 cm2 of skin.
The method of application to the skin varies depending on the formulation, and can be by painting, spraying, pasting, etc.
運動効果の持続又は向上方法
本発明は、運動に際して、(A)脂肪の燃焼を促進する成分、及び(B)発汗を促進する成分を含む製剤(本発明の皮膚外用剤)を皮膚に適用する工程を含む運動効果の持続又は向上方法を包含する。
この運動効果持続又は向上方法は、皮膚又は身体の温度(特に、運動により上昇した皮膚又は身体の温度)の維持又は上昇方法、発汗(特に、運動により増大した発汗)の維持又は増大方法、血流(特に、運動により増大した血流)の維持又は増大方法、爽快状態の維持又は向上方法、運動実感の維持又は向上方法、運動体感又は感覚の維持又は増大方法、温感(特に、運動により上昇した温感)の維持又は向上方法、発汗実感(特に、運動により上昇した発汗実感)の維持又は向上方法、血流増大感(特に、運動により上昇した血流増大感)の維持又は向上方法、爽快感の維持又は向上方法であり得る。
Method for maintaining or improving the effects of exercise The present invention encompasses a method for maintaining or improving the effects of exercise, comprising the step of applying to the skin, during exercise, a preparation (the topical skin preparation of the present invention) containing (A) a component that promotes fat burning and (B) a component that promotes sweating.
This method of maintaining or improving the effect of exercise may be a method of maintaining or increasing skin or body temperature (particularly, skin or body temperature increased by exercise), a method of maintaining or increasing sweating (particularly, increased sweating by exercise), a method of maintaining or increasing blood flow (particularly, increased blood flow by exercise), a method of maintaining or improving a state of exhilaration, a method of maintaining or improving the sensation of exercise, a method of maintaining or increasing the sensation or feeling of exercise, a method of maintaining or improving the sensation of warmth (particularly, the sensation of warmth increased by exercise), a method of maintaining or improving the sensation of sweating (particularly, the sensation of sweating increased by exercise), a method of maintaining or improving the sensation of increased blood flow (particularly the sensation of increased blood flow increased by exercise), or a method of maintaining or improving a feeling of exhilaration.
本発明の各方法は、医療方法を含まない。即ち、治療方法や、医療方法としての予防方法などを含まない。
本発明方法における各成分の種類や量、用量、用法、適用箇所などは、本発明の皮膚外用剤について説明した通りである。
The methods of the present invention do not include medical methods, i.e., they do not include treatment methods or preventive methods as medical methods.
The type and amount of each component, dosage, method of use, application site, etc. in the method of the present invention are as explained for the topical skin preparation of the present invention.
以下、実施例を挙げて、本発明をより詳細に説明するが、本発明はこれらに限定されない。 The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these.
(1)体表面温度の評価
恒温環境(22℃±1℃)にて、20~30代の被験者4名(女性4名)が、エアロバイク(登録商標、ヤマトヒューマン(株)、YAB-881N)を、一定負荷条件(負荷3)にて15分間漕ぎ、エアロバイク運動の直後にサーモグラフィー(NEC Avio Infrared Technologies Co., Ltd.、TVS-500EX)にて体表面の皮膚(首の前面、手のひら、手の甲)の温度を計測した。直ちに汗を拭い、表1に記載の各組成物を首、手のひら、手の甲に約2mg/cm2で塗布した後、座位にて安静にし、運動終了後10分後、及び20分後に、組成物塗布部位の体表面温度を計測し、運動後の体表面温度の変化率を、下記式(1)に従い算出した。
運動後の体表面温度変化率
=[(運動10分後又は20分後の体表面温度-運動直後の体表面温度)/運動直後の体表面温度]×100(%)
・・・・・・・式(1)
なお、比較例1では組成物は塗布せず、体表面温度のみを計測した。
(1) Evaluation of body surface temperature In a constant temperature environment (22°C ± 1°C), four subjects (four women) in their 20s and 30s pedaled an exercise bike (registered trademark, Yamato Human Co., Ltd., YAB-881N) for 15 minutes under constant load conditions (load 3), and immediately after the exercise on the exercise bike, the temperature of the skin on the body surface (front of the neck, palm, back of the hand) was measured using a thermograph (NEC Avio Infrared Technologies Co., Ltd., TVS-500EX). Immediately after wiping off sweat, each composition listed in Table 1 was applied to the neck, palm, and back of the hand at about 2 mg/ cm2 , and then the subjects were allowed to rest in a seated position. 10 minutes and 20 minutes after the end of the exercise, the body surface temperature of the composition application site was measured, and the rate of change in body surface temperature after exercise was calculated according to the following formula (1).
Body surface temperature change rate after exercise = [(body surface temperature 10 or 20 minutes after exercise - body surface temperature immediately after exercise) / body surface temperature immediately after exercise] x 100 (%)
・・・・・・Formula (1)
In Comparative Example 1, no composition was applied, and only the body surface temperature was measured.
体表面温度変化率の平均値を表2及び図1~図3に記載する。
実施例1、2の皮膚外用剤を運動後に塗布することにより、運動直後より10分後又は20分後の方が体表面温度は概ね上昇した。一方、本発明の(A)成分、(B)成分の何れも含まない比較例2の皮膚外用剤を運動後に塗布した場合、運動直後より10分後又は20分後の方が体表面温度は低くなった。従って、本発明の(A)成分、(B)成分の配合により、運動後に体表面温度が上昇したことが分かる。
また、本発明の(A)成分及び(B)成分を含み、バニリルブチルを含まない実施例2の皮膚外用剤と、本発明の(A)成分及び(B)成分とバニリルブチルを含む実施例1の皮膚外用剤とでは、体表面温度変化率は同程度であった。バニリルブチルを含むが本発明の(A)成分及び(B)成分を含まない比較例2の皮膚外用剤を塗布した場合は、体温変化率はマイナスになったことを考慮すると、バニリルブチルと、本発明の(A)成分及び(B)成分とは、相乗的に作用して、運動後の体表面温度を上昇させたことが分かる。
By applying the skin preparations of Examples 1 and 2 after exercise, the body surface temperature was generally higher 10 or 20 minutes after exercise than immediately after exercise. On the other hand, when the skin preparation of Comparative Example 2, which does not contain either component (A) or component (B) of the present invention, was applied after exercise, the body surface temperature was lower 10 or 20 minutes after exercise than immediately after exercise. Therefore, it can be seen that the incorporation of components (A) and (B) of the present invention increases the body surface temperature after exercise.
In addition, the skin topical preparation of Example 2, which contains the components (A) and (B) of the present invention but does not contain vanillyl butyl, and the skin topical preparation of Example 1, which contains the components (A) and (B) of the present invention and vanillyl butyl, showed similar body surface temperature change rates. Considering that the skin topical preparation of Comparative Example 2, which contains vanillyl butyl but does not contain the components (A) and (B) of the present invention, showed a negative body temperature change rate when applied, it can be seen that vanillyl butyl and the components (A) and (B) of the present invention act synergistically to increase the body surface temperature after exercise.
(2)官能試験
「(1)体表面温度の評価」試験において、被験者4名が感じた感覚を、官能試験により評価した。官能試験は、(1)爽快感、(2)温感(ぽかぽかとした感覚)、及び(3)発汗感について、ビジュアルアナログスケール(VAS)法で実施した。VASは、各質問項目について、左端(0)が「全く感じない」で最悪の状態、右端(100)が「大変強く感じる」で最良の状態を表す10cm線分を用い、各被験者は感じた感覚の大きさを、10cm線分に斜線を入れることで回答した。なお、被験者には製剤の内容が識別できないようにして官能試験を実施した。
(2) Sensory Test In the test "(1) Evaluation of Body Surface Temperature", the sensations felt by four subjects were evaluated by a sensory test. The sensory test was conducted using a visual analog scale (VAS) method for (1) refreshing sensation, (2) warm sensation (warm sensation), and (3) sweating sensation. For each question item, the VAS used a 10 cm line with the left end (0) representing "no sensation at all" being the worst state and the right end (100) representing "very strong sensation" being the best state, and each subject answered the magnitude of the sensation they felt by drawing a diagonal line on the 10 cm line. The sensory test was conducted without subjects being able to identify the contents of the formulation.
VASスコアは、どの項目も概ね時間の経過とともに低下傾向に変化することが確認された。
下記式(2)に従い、無塗布の場合(比較例1)の、運動10分又は20分経過することによるVASスコアの低下を基準とし、各外用組成物を塗布した場合のVASスコア低下抑制の割合を算出し、効果感低下抑制率とした。
効果感低下抑制率(%)
={1-(各例の運動直後のVAS値-各例の運動10分後又は20分後のVAS値)/(比較例1の運動直後のVAS値-比較例1の運動10分後又は20分後のVAS値)}×100
・・・・・・・(2)
It was confirmed that the VAS scores for all items generally showed a downward trend over time.
According to the following formula (2), the decrease in VAS score after 10 or 20 minutes of exercise in the case of no application (Comparative Example 1) was used as the standard, and the rate of inhibition of the decrease in VAS score when each topical composition was applied was calculated, and this was taken as the inhibition rate of decrease in feeling of efficacy.
Inhibition rate of decrease in efficacy (%)
= {1 - (VAS value immediately after exercise for each example - VAS value 10 or 20 minutes after exercise for each example) / (VAS value immediately after exercise for Comparative Example 1 - VAS value 10 or 20 minutes after exercise for Comparative Example 1)} x 100
・・・・・・・・・(2)
結果を表3に示す。
実施例1、2の皮膚外用剤を運動後に塗布することにより、運動10分後、20分後において「爽快感」「温感」「発汗感」の何れの項目においても、高い効果感低下抑制効果があることが確認された。従って、本発明の(A)成分、(B)成分の配合により、運動効果感の持続効果が高まったことが分かる。
また、バニリルブチルを含むが本発明の(A)成分及び(B)成分を含まない比較例2の皮膚外用剤を塗布した場合は発汗感低下の抑制率が3.9%と非常に低く、また、本発明の(A)成分及び(B)成分を含み、バニリルブチルを含まない実施例2の皮膚外用剤では31.5%であるのに対して、本発明の(A)成分及び(B)成分とバニリルブチルを含む実施例1の皮膚外用剤とでは、発汗感低下抑制率45.5%と非常に高かった。バニリルブチルと、本発明の(A)成分及び(B)成分とは、相乗的に作用して、運動後の効果感を維持させたことが分かる。
It was confirmed that the application of the skin topicals of Examples 1 and 2 after exercise had a high inhibitory effect on the decline in the sense of effectiveness in all of the categories of "refreshing sensation,""warmsensation," and "sweating sensation" 10 and 20 minutes after exercise. Therefore, it can be seen that the blending of components (A) and (B) of the present invention enhances the sustained effect of the sense of effectiveness of exercise.
In addition, when the skin preparation of Comparative Example 2, which contains vanillyl butyl but does not contain the components (A) and (B) of the present invention, was applied, the inhibition rate of the decrease in the sense of sweating was very low at 3.9%, and the skin preparation of Example 2, which contains the components (A) and (B) of the present invention but does not contain vanillyl butyl, was 31.5%, whereas the skin preparation of Example 1, which contains the components (A) and (B) of the present invention and vanillyl butyl, was very high at 45.5%. It can be seen that vanillyl butyl and the components (A) and (B) of the present invention act synergistically to maintain the feeling of effect after exercise.
(3)体表面温度・発汗量の評価
20代~40代の被験者5名(男性3名、女性2名)が、プロテイン含有飲料を飲んだ後に、エアロバイク(登録商標、ヤマトヒューマン(株)、YAB-881N)を一定負荷条件(負荷3)で20分間漕ぎ、エアロバイク運動直後、10分後、及び20分後に、サーモグラフィー(NEC Avio Infrared Technologies Co., Ltd.、TVS-500EX)を用いて、体表面の皮膚(首の前面、手のひら、手の甲)の温度を計測した。また、エアロバイク運動の後10分間の前腕の発汗量と、10分後~20分後の10分間の発汗量を、SKN-2000 PERSPIRATION METER(Nishizawa Electric Meters Mfg. Co., Ltd.)を用いて測定した。
被験者5名は、上記運動及び測定を2回行い、2回のうち一方は「皮膚外用剤の塗布なし」、2回のうち他方は「運動直後に、実施例1のジェル状皮膚外用剤を各部位に、約2mg/cm2塗布」の条件とした。
プロテイン含有飲料は、ブラックジンジャー抽出物及び、トウガラシエキスを配合した、プロテイン末を、タンパク質量7g/回にて、水150mLと混ぜたものを飲用した。
(3) Evaluation of body surface temperature and sweat amount Five subjects (three men and two women) in their 20s to 40s drank a protein-containing beverage and then pedaled an exercise bike (registered trademark, Yamato Human Co., Ltd., YAB-881N) for 20 minutes under constant load conditions (load 3). The temperature of the skin on the body surface (front of the neck, palm, back of the hand) was measured using a thermograph (NEC Avio Infrared Technologies Co., Ltd., TVS-500EX) immediately after the exercise bike, 10 minutes later, and 20 minutes later. In addition, the amount of sweat on the forearm for 10 minutes after the exercise bike and the amount of sweat for 10 minutes from 10 minutes to 20 minutes later were measured using an SKN-2000 PERSPIRATION METER (Nishizawa Electric Meters Mfg. Co., Ltd.).
Five subjects performed the above exercise and measurements twice, one of which was performed without application of any topical skin preparation, and the other was performed with approximately 2 mg/ cm2 of the gel-type topical skin preparation of Example 1 applied to each area immediately after exercise.
The protein-containing beverage consisted of a protein powder containing black ginger extract and chili pepper extract, mixed with 150 mL of water at a protein content of 7 g per session.
結果を表4に示す。
表4中の体表面温度の項目の数値は、上記式(1)にて算出した運動後の体温変化率の平均値である。
また、発汗量として10分間の発汗量の積算値の平均値をとり、皮膚外用剤を塗布しない場合の運動直後から10分間の発汗量を基準とし、下記式(3)にて発汗量比を算出した。発汗量比も表4に示す。
発汗量比
=運動直後から運動10分後までの10分間の発汗量又は運動10分後から20分後までの10分間の発汗量)/塗布なしの場合における運動直後から運動10分後までの10分間の発汗量
・・・・・・・(3)
The results are shown in Table 4.
The numerical values in the body surface temperature column in Table 4 are the average values of the rate of change in body temperature after exercise calculated using the above formula (1).
The average value of the accumulated amount of sweat for 10 minutes was calculated as the amount of sweat, and the amount of sweat for 10 minutes immediately after exercise without application of the skin preparation was used as the standard to calculate the ratio of the amount of sweat according to the following formula (3). The ratio of the amount of sweat is also shown in Table 4.
Sweat rate ratio = sweat rate for 10 minutes from immediately after exercise to 10 minutes after exercise or sweat rate for 10 minutes from 10 minutes to 20 minutes after exercise) / sweat rate for 10 minutes from immediately after exercise to 10 minutes after exercise without application
・・・・・・・・・(3)
本発明の皮膚外用剤を運動後に塗布することにより、無塗布の場合に比べて、体表面温度の上昇率が大きかった。また、無塗布の場合は、運動後に体表面温度が低下する場合もあるが、本発明の皮膚外用剤を運動直後に塗布することにより、運動後に一旦体表面温度が低下しても、その後速やかに上昇に転じた。皮膚外用剤の使用による体表面温度の上昇は、特に女性において顕著であった。
また、発汗量は、皮膚外用剤の使用により明らかに増大し、さらに増加傾向は、運動後に時間が経過しても維持され、総発汗量は外用剤を塗布しない場合に比べ、顕著に増大することが確認された。
By applying the skin preparation of the present invention after exercise, the increase rate of body surface temperature is larger than that of not applying it.In addition, when not applying it, body surface temperature may decrease after exercise, but by applying the skin preparation of the present invention immediately after exercise, even if body surface temperature decreases once after exercise, it will then rise again quickly.The increase in body surface temperature by using the skin preparation is particularly noticeable in women.
In addition, it was confirmed that the amount of sweat produced was clearly increased by the use of the topical skin preparation, and that this increasing trend was maintained even after some time had passed after exercise, with the total amount of sweat produced being significantly greater than when no topical preparation was applied.
また、皮膚外用剤の使用による体感を各被験者にインタビューした結果、「無塗布の場合は冷え易い箇所が、塗布により冷えなかった。」「皮膚外用剤の塗布後しばらくすると掌や首がじんわり暖まったが、無塗布の場合はこのような温感は感じられなかった。」「無塗布の場合は、運動20分後には汗をかいた身体が冷えた感覚があったが、運動直後に皮膚外用剤を塗布し20分経過後も、汗をかいた身体がじんわり暖かく、冷えていなかった。」というコメントが得られた。官能評価では、本発明の皮膚外用剤を使用することにより、運動後の体温上昇の体感が大きくなることが確認された。皮膚外用剤の使用による体表面温度の上昇の体感は、特に女性において顕著であった。 In addition, when each subject was interviewed about the sensation of using the topical skin preparation, the following comments were obtained: "Areas that tend to get cold without application did not get cold after application.", "After application of the topical skin preparation, the palms and neck gradually warmed up a while, but without application, this warm sensation was not felt.", and "Without application, the sweaty body felt cold 20 minutes after exercise, but even 20 minutes after application of the topical skin preparation immediately after exercise, the sweaty body was gradually warm and not cold." In the sensory evaluation, it was confirmed that the use of the topical skin preparation of the present invention increased the sensation of a rise in body temperature after exercise. The sensation of a rise in body surface temperature due to use of the topical skin preparation was particularly noticeable in women.
以下に、本発明の皮膚外用剤の製剤処方例を示す。処方例の「%」は「重量%」を示す。
処方例1(ジェルクリーム)
精製水 残量
エタノール 10%
スクワラン 5%
エチルヘキサン酸セチル 1%
カルボマー 0.5%
ジメチコン 0.5%
BG 5%
DPG 5%
TEA 適量
フェノキシエタノール 0.3%
イソステアリン酸PEG-20ソルビタン 0.5%
セスキオレイン酸ソルビタン 0.4%
ヒアルロン酸 0.05%
バニリルブチル 0.02%
タンブリッサトリコフィラ葉エキス 0.01%
フキ葉/茎エキス 0.005%
レピジウムメイエニエキス 0.003%
カルニチン 0.1%
ハマメリス葉エキス 0.1%
ベルガモット油 0.1%
Examples of formulations of the topical skin preparations of the present invention are shown below. In the formulation examples, "%" indicates "% by weight."
Formulation example 1 (gel cream)
Purified water, remaining ethanol 10%
Squalane 5%
Cetyl ethylhexanoate 1%
Carbomer 0.5%
Dimethicone 0.5%
BG 5%
DPG 5%
TEA Appropriate amount Phenoxyethanol 0.3%
PEG-20 sorbitan isostearate 0.5%
Sorbitan sesquioleate 0.4%
Hyaluronic acid 0.05%
Vanillyl butyl 0.02%
Tambourissa Trichophylla Leaf Extract 0.01%
Butterbur leaf/stem extract 0.005%
Lepidium meyenii extract 0.003%
Carnitine 0.1%
Hamamelis Leaf Extract 0.1%
Bergamot oil 0.1%
処方例2(ジェル)
精製水 残量
エタノール 10%
1,3-プロパンジオール 7%
ペンタンジオール 1%
アクリル酸メタクリル酸アルキル共重合体 0.7%
キサンタンガム 0.05%
TEA 適量
メチルパラベン 0.1%
ポリオキシエチレン硬化ヒマシ油 0.5%
ヒアルロン酸 0.01%
バニリルブチル 0.01%
タンブリッサトリコフィラ葉エキス 0.05%
フキ葉/茎エキス 0.001%
レピジウムメイエニエキス 0.001%
カルニチン 0.2%
l-メントール 0.2%
ユーカリ油 0.05%
香料 0.1%
Formulation Example 2 (Gel)
Purified water, remaining ethanol 10%
1,3-propanediol 7%
Pentanediol 1%
Acrylic acid/alkyl methacrylate copolymer 0.7%
Xanthan gum 0.05%
TEA, appropriate amount, methylparaben, 0.1%
Polyoxyethylene hydrogenated castor oil 0.5%
Hyaluronic acid 0.01%
Vanillyl butyl 0.01%
Tambourissa Trichophylla Leaf Extract 0.05%
Butterbur leaf/stem extract 0.001%
Lepidium meyenii extract 0.001%
Carnitine 0.2%
l-Menthol 0.2%
Eucalyptus oil 0.05%
Fragrance: 0.1%
処方例3(ジェル)
精製水 残量
エタノール 10%
1,3-プロパンジオール 5%
ペンタンジオール 1%
アクリル酸メタクリル酸アルキル共重合体 0.5%
キサンタンガム 0.05%
TEA 適量
メチルパラベン 0.1%
ポリオキシエチレン硬化ヒマシ油 0.5%
ヒアルロン酸 0.01%
フィトソニック(セダーマ) 0.1%
高麗人参エキス 0.01%
フキ葉/茎エキス 0.001%
レピジウムメイエニエキス 0.001%
カルニチン 0.2%
l-メントール 0.2%
グレープフルーツ油 0.05%
香料 0.1%
Formulation example 3 (gel)
Purified water, remaining ethanol 10%
1,3-propanediol 5%
Pentanediol 1%
Acrylic acid/alkyl methacrylate copolymer 0.5%
Xanthan gum 0.05%
TEA, appropriate amount, methylparaben, 0.1%
Polyoxyethylene hydrogenated castor oil 0.5%
Hyaluronic acid 0.01%
Phytosonic (Sederma) 0.1%
Korean ginseng extract 0.01%
Butterbur leaf/stem extract 0.001%
Lepidium meyenii extract 0.001%
Carnitine 0.2%
l-Menthol 0.2%
Grapefruit oil 0.05%
Fragrance: 0.1%
処方例4(ジェル)
精製水 残量
エタノール 8%
BG 10%
DPG 5%
アクリル酸メタクリル酸アルキル共重合体 0.5%
キサンタンガム 0.05%
TEA 適量
メチルパラベン 0.1%
ポリオキシエチレン硬化ヒマシ油 0.5%
ヒアルロン酸 0.02%
ノナン酸バニリルアミド 0.005%
アシタバエキス 0.1%
フキ葉/茎エキス 0.001%
ニンジンエキス 0.001%
カルニチン 0.2%
l-メントール 0.2%
ラベンダー油 0.05%
香料 0.1%
Formulation Example 4 (Gel)
Purified water, remaining ethanol 8%
BG 10%
DPG 5%
Acrylic acid/alkyl methacrylate copolymer 0.5%
Xanthan gum 0.05%
TEA, appropriate amount, methylparaben, 0.1%
Polyoxyethylene hydrogenated castor oil 0.5%
Hyaluronic acid 0.02%
Nonanoic acid vanillylamide 0.005%
Angelica keiskei extract 0.1%
Butterbur leaf/stem extract 0.001%
Carrot extract 0.001%
Carnitine 0.2%
l-Menthol 0.2%
Lavender oil 0.05%
Fragrance: 0.1%
処方例5(ローション)
精製水 残量
エタノール 3%
1,3-プロパンジオール 7%
グリセリン 3%
ペンタンジオール 1%
カラギーナン 0.05%
メチルパラベン 0.2%
ポリオキシエチレン硬化ヒマシ油 0.3%
トウガラシエキス 0.001%
タンブリッサトリコフィラ葉エキス 0.0001%
フキ葉/茎エキス 0.0005%
レピジウムメイエニエキス 0.005%
カルニチン 0.05%
香料 0.05%
Formulation Example 5 (Lotion)
Purified water, remaining ethanol 3%
1,3-propanediol 7%
Glycerin 3%
Pentanediol 1%
Carrageenan 0.05%
Methylparaben 0.2%
Polyoxyethylene hydrogenated castor oil 0.3%
Capsicum extract 0.001%
Tambourissa Trichophylla Leaf Extract 0.0001%
Butterbur leaf/stem extract 0.0005%
Lepidium meyenii extract 0.005%
Carnitine 0.05%
Fragrance: 0.05%
処方例6(乳液)
精製水 残量
ワセリン 5%
流動パラフィン 2%
トリ(カプリル酸/カプリン酸)グリセリル 3%
ヒドロキシエチルセルロース 0.5%
ジメチコン 0.5%
BG 5%
グリセリン 5%
TEA 適量
ヘキサンジオール 2%
フェノキシエタノール 0.5%
イソステアリン酸PEG-20ソルビタン 1%
ステアリン酸グリセリル 0.5%
バニリルブチル 0.005%
タンブリッサトリコフィラ葉エキス 0.03%
フキ葉/茎エキス 0.01%
レピジウムメイエニエキス 0.001%
カルニチン 0.01%
チャエキス 0.05%
カンフル 0.01%
香料 0.1%
Formulation Example 6 (lotion)
Purified water, remaining amount is Vaseline 5%
Liquid paraffin 2%
Caprylic/capric triglyceride 3%
Hydroxyethylcellulose 0.5%
Dimethicone 0.5%
BG 5%
Glycerin 5%
TEA Appropriate amount Hexanediol 2%
Phenoxyethanol 0.5%
PEG-20 sorbitan isostearate 1%
Glyceryl stearate 0.5%
Vanillyl butyl 0.005%
Tambourissa Trichophylla Leaf Extract 0.03%
Butterbur leaf/stem extract 0.01%
Lepidium meyenii extract 0.001%
Carnitine 0.01%
Tea extract 0.05%
Camphor 0.01%
Fragrance: 0.1%
処方例7(スプレー)
精製水 残量
エタノール 40%
BG 5%
PPG-6デシルテトラデセス 0.3%
ヒアルロン酸 0.01%
バニリルブチル 0.03%
タンブリッサトリコフィラ葉エキス 0.001%
フキ葉/茎エキス 0.001%
レピジウムメイエニエキス 0.005%
カルニチン 0.005%
l-メントール 0.5%
ベルガモット油 0.05%
香料 0.05%
タルク 3%
Formulation Example 7 (Spray)
Purified water, remaining ethanol 40%
BG 5%
PPG-6 decyltetradeceth 0.3%
Hyaluronic acid 0.01%
Vanillyl butyl 0.03%
Tambourissa Trichophylla Leaf Extract 0.001%
Butterbur leaf/stem extract 0.001%
Lepidium meyenii extract 0.005%
Carnitine 0.005%
l-Menthol 0.5%
Bergamot oil 0.05%
Fragrance: 0.05%
Talc 3%
処方例8(ジェル)
精製水 残量
エタノール 10%
1,3-ブチレングリコール 5%
ペンタンジオール 1.5%
アクリル酸メタクリル酸アルキル共重合体 0.6%
ヒドロキシエチルセルロース 0.1%
TEA 適量
メチルパラベン 0.05%
ポリオキシエチレン硬化ヒマシ油 0.5%
ヒアルロン酸 0.01%
バニリルブチル 0.01%
タンブリッサトリコフィラ葉エキス 0.05%
フキ葉/茎エキス 0.001%
ステビアエキス 0.001%
カルニチン 0.2%
l-メントール 0.2%
ユーカリ油 0.05%
香料 0.1%
Formulation Example 8 (Gel)
Purified water, remaining ethanol 10%
1,3-butylene glycol 5%
Pentanediol 1.5%
Acrylic acid/alkyl methacrylate copolymer 0.6%
Hydroxyethyl cellulose 0.1%
TEA, appropriate amount, methylparaben, 0.05%
Polyoxyethylene hydrogenated castor oil 0.5%
Hyaluronic acid 0.01%
Vanillyl butyl 0.01%
Tambourissa Trichophylla Leaf Extract 0.05%
Butterbur leaf/stem extract 0.001%
Stevia extract 0.001%
Carnitine 0.2%
l-Menthol 0.2%
Eucalyptus oil 0.05%
Fragrance: 0.1%
処方例9(ジェルクリーム)
精製水 残量
エタノール 8%
スクワラン 5%
エチルヘキサン酸セチル 1%
カルボマー 0.5%
ジメチコン 0.2%
1,3-ブチレングリコール 5%
DPG 2%
TEA 適量
フェノキシエタノール 0.3%
イソステアリン酸PEG-20ソルビタン 0.5%
セスキオレイン酸ソルビタン 0.4%
ヒアルロン酸 0.05%
バニリルブチル 0.02%
バチルス/ダイス発酵エキス 0.01%
タンブリッサトリコフィラ葉エキス 0.05%
レピジウムメイエニエキス 0.003%
カルニチン 0.1%
グレープフルーツ油 0.05%
ベルガモット油 0.03%
Formulation Example 9 (Gel Cream)
Purified water, remaining ethanol 8%
Squalane 5%
Cetyl ethylhexanoate 1%
Carbomer 0.5%
Dimethicone 0.2%
1,3-butylene glycol 5%
DPG 2%
TEA Appropriate amount Phenoxyethanol 0.3%
PEG-20 sorbitan isostearate 0.5%
Sorbitan sesquioleate 0.4%
Hyaluronic acid 0.05%
Vanillyl butyl 0.02%
Bacillus/soybean fermentation extract 0.01%
Tambourissa Trichophylla Leaf Extract 0.05%
Lepidium meyenii extract 0.003%
Carnitine 0.1%
Grapefruit oil 0.05%
Bergamot oil 0.03%
本発明の皮膚外用剤を、運動に際して皮膚に適用することで、運動効果が持続又は向上する。従って、軽い運動でも大きな運動効果が得られ、満足感が大きくなる。近年、運動人口が増加しており、ほとんどの人は軽い運動をしているため、本発明の皮膚外用剤は、ニーズに合った商品価値が高いものである。 By applying the topical skin preparation of the present invention to the skin during exercise, the effects of exercise are sustained or improved. Therefore, even light exercise can have a significant effect, resulting in a greater sense of satisfaction. In recent years, the number of people who exercise has increased, and most people now do light exercise, so the topical skin preparation of the present invention is a highly valuable product that meets these needs.
Claims (2)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019125547 | 2019-07-04 | ||
| JP2019125547 | 2019-07-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021011475A JP2021011475A (en) | 2021-02-04 |
| JP7591881B2 true JP7591881B2 (en) | 2024-11-29 |
Family
ID=74227926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020115937A Active JP7591881B2 (en) | 2019-07-04 | 2020-07-03 | Skin preparations |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7591881B2 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004244355A (en) | 2003-02-13 | 2004-09-02 | Quimibel Sl | Skin care composition and kit for shape-up use |
| JP2015229653A (en) | 2014-06-05 | 2015-12-21 | ロート製薬株式会社 | Moisturizer |
| WO2018230733A1 (en) | 2017-06-16 | 2018-12-20 | マルホ株式会社 | External preparation for skin |
-
2020
- 2020-07-03 JP JP2020115937A patent/JP7591881B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004244355A (en) | 2003-02-13 | 2004-09-02 | Quimibel Sl | Skin care composition and kit for shape-up use |
| JP2015229653A (en) | 2014-06-05 | 2015-12-21 | ロート製薬株式会社 | Moisturizer |
| WO2018230733A1 (en) | 2017-06-16 | 2018-12-20 | マルホ株式会社 | External preparation for skin |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021011475A (en) | 2021-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104000752B (en) | Ginger extract for stem cell protection | |
| CN101795732B (en) | Magnolia extract containing compositions | |
| US7994141B2 (en) | Compositions comprising compounds of natural origin for damaged skin | |
| JP2006514657A (en) | Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis | |
| JP2012041302A (en) | Skin cosmetic | |
| JP2025026865A (en) | External Composition | |
| JP6043145B2 (en) | Skin external composition for body odor control | |
| EP3643295A1 (en) | Composition containing cirsium japonicum extract as active ingredient for stimulating melanogenesis | |
| JP2021167350A (en) | Skin external composition | |
| KR20180083719A (en) | A aromatic composition having anti-stress and fatigue relaxing, and a cosmetic composition containing the same | |
| CN103180016B (en) | Comprise compositionss of panlownin and/or Paulownia extract and application thereof | |
| JP2005060234A (en) | External preparation for skin | |
| JP2004010526A (en) | External preparation for skin | |
| KR20090130584A (en) | Cosmetic composition for skin whitening and wrinkle improvement containing complex herbal extract as an active ingredient | |
| JP4637441B2 (en) | Skin composition containing ascorbic acid | |
| JP4684269B2 (en) | Skin composition containing ascorbic acid | |
| JP4152324B2 (en) | Composition for external use | |
| JP4755841B2 (en) | Silymarin-containing topical skin preparation | |
| CN104546523A (en) | Compositions comprising extract of paulownia tomentosa wood and uses thereof | |
| JP7591881B2 (en) | Skin preparations | |
| JP2009269851A (en) | Inhibitor of prostaglandin e2 production and its utilization | |
| JP2008007526A (en) | External composition | |
| JP2020125254A (en) | Cosmetics, cell protectant against ultraviolet rays, and light aging inhibitor | |
| JP4105103B2 (en) | Composition for external use | |
| JP2004359674A (en) | Slimming kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230124 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240229 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240423 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240709 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241002 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20241010 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20241101 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20241119 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7591881 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |



